UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | Y
Number of items: 379.

A

Adib, T.R.; (2005) Gene expression microarrays of serous ovarian adenocarcinoma. Doctoral thesis , University of London. Green open access
file

Ah- See, ML; Burcombe, RJ; Daley, FM; Richman, P; Padhani, AR; Bentzen, SM; Fox, SB; ... Makris, A; + view all (2005) Evaluation of tunour microvessel density and pericyte coverge index following neoadjuvant chemotherapy in primary breast cancer. In: (pp. 42s-42s).

Ah-See, M; Makris, A; Taylor, NJ; Stirling, JJ; Daley, FM; Richman, P; Harris, A; ... Padhani, AR; + view all (2005) Correlating breast cancer and hypoxia status with MRI features. In: (pp. S205-).

Ah-See, M; Padhani, AR; Taylor, NJ; Harris, AL; Burcombe, RJ; Fox, SB; Richman, PI; ... Makris, M; + view all (2005) Lack of correlation between microvessel density & pericyte coverage index with breast cancer biposies & functional dynamic contrast-enhanced MRI-derived vascular parameters. In: (pp. S74-S75).

Ah-See, MW; Harris, AL; Burcombe, RJ; Fox, SB; Richman, PI; Daley, FM; Padhani, AR; ... Makris, A; + view all (2005) Evaluation of the effects of neoadjuvant chemotherapy on tumour microvessel density(MVD), pericyte coverage index(PCI), & vascular enodthelial growth factor(VEGF)in primary breast cancer. In: (pp. S224-).

Ahmed, F.; (2005) Homing and engraftment of CD34+ cells in the NOD/SCID model. Doctoral thesis , University of London. Green open access
file

Al-Adnani, M; Cannon, SR; Flanagan, AM; (2005) Chordomas do not express CD10 and renal cell carcinoma (RCC) antigen: an immunohistochemical study. Histopathology , 47 (5) pp. 535-537. 10.1111/j.1365-2559.2005.02131.x.

Al-Adnani, M; Idowu, B; Yu, L; Diss, TC; Lam, L; Gale, RE; O'Dell, E; (2005) Detection of a new mutation in fibrous dysplasia using a modified site directed mutagenesis methodology. In: JOURNAL OF PATHOLOGY. (pp. 7 - 7). JOHN WILEY & SONS LTD

Al-Adnani, M; Idowu, B; Yu, T; Diss, TC; Gale, RE; O'Dell, E; Flanagan, AM; (2005) A simple and reliable method for the molecular diagnosis of fibrous dysplasia. In: MODERN PATHOLOGY. (pp. 10A - 11A). NATURE PUBLISHING GROUP

Al-Dabbagh, R; Barrett, AW; Diss, T; Speight, PM; (2005) HPV is not associated with intra-oral squamous cell carcinoma. In: (pp. p. 1).

Alonzi, R; Hoskin, P; (2005) Novel therapies in bladder cancer. CLINICAL ONCOLOGY , 17 (7) pp. 524-538.

Andy, S; (2005) My dad’s fight with lung cancer. Daily Express pp. 30-31.

Arce, F; Gatjens-Boniche, O; Vargas, E; Valverde, B; Diaz, C; (2005) Apoptotic events induced by naturally occurring retinoids ATRA and 13-cis retinoic acid on human hepatoma cell lines Hep3B and HepG2. CANCER LETTERS , 229 (2) pp. 271-281. 10.1016/j.canlet.2005.06.047.

Arkenau, H; Kubicka, S; Greil, R; Schmoll, H; Seufferlein, T; Greaven, U; Grothey, A; ... Porschen, R; + view all (2005) Infusional 5-fluorouracil/folinic acid plus oxaliplatin (FUFOX) versus Capecitabine plus oxaliplatin (CAPOX) as first line treatment of metastatic colorectal carcinoma (MCRC): results of the safety and efficacy analysis. EJC SUPPL , 3 (2) 168 - 168.

Arkenau, H; Porschen, R; (2005) Adjuvante Therapie des Kolonkarzinoms. In: Schoelmerich, J and Schmiegel, W, (eds.) Leitfaden Kolorektales Karzinom. (pp. 175-183). Uni-Med.-Verlag: Bremen, Germany.

Arkenau, HT; Mussig, O; Buhr, T; Jend, HH; Porschen, R; (2005) Microangiopathic hemolytic anemia (MAHA) as paraneoplastic syndrome in metastasized signet ring cell carcinomas: Case reports and review of the literature. ZEITSCHRIFT FUR GASTROENTEROLOGIE , 43 (8) pp. 719-722. 10.1055/s-2005-858259.

Arkenau, HT; Rettig, K; Porschen, R; (2005) Adjuvant chemotherapy in curative resected colon carcinoma: 5-fluorouracil/leucovorin versus high-dose 5-fluorouracil 24-h infusion/leucovorin versus high-dose 5-fluorouracil 24-h infusion. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE , 20 (3) pp. 258-261. 10.1007/s00384-004-0657-6.

B

BBC, NB; (2005) Lung cancer scientist dies at 92. UNSPECIFIED

BBC, NO; (2005) 'Freeze therapy' for lung cancers. UNSPECIFIED

BBC, NO; (2005) Thalidomide slows cancer disease. UNSPECIFIED

BBC, NO; (2005) Warning to heed lung cancer signs. UNSPECIFIED

Bates, AW; (2005) Emblematic monsters: unnatural conceptions and deformed births in early modern Europe. (Vol.77).

Bax, BE; Richfield, L; Bain, MD; Mehta, AB; Chalmers, RA; Rampling, MW; (2005) Haemorheology in Gaucher disease. European Journal of Haematology , 75 (3) pp. 252-258.

Beck, M; Cox, TM; Mehta, AB; Widmer, U; (2005) Lysosomal Diseases, Natural course, pathology and therapy. [Book]. (Vol.95, su). Taylor & Francis

Beck, S; (2005) Molecular variety club: (Epi)genetic resources for MHC/LRC-linked disease and evolution. In: TISSUE ANTIGENS. (pp. 357 - 358). BLACKWELL PUBLISHING

Beck, S; Berlin, K; Eckhardt, F; (2005) Das Epigenomprojekt. MEDIZINISCHE GENETIK , 17 (3) pp. 46-50.

Begent, RHJ; Kerr, P; Parkinson, H; Reddington, F; Wilkinson, JM; (2005) NCRI Informatics initiative. UNSPECIFIED

Benjamin, R; Streck, C; Ng, CYC; Singh, N; Khwaja, A; Pizzey, A; McIntosh, J; ... Nathwani, AC; + view all (2005) Effect of substained expression of human interferon-β by rAAV vector medicated gene transfer in xenograft models of acute leukaemia. In:

Bentzen, SM; Atasoy, BM; Daley, FM; Dische, S; Richman, PI; Saunders, MI; Trott, KR; (2005) Epidermal growth factor receptor expression in pre-treatment biopsies from head and neck squamous cell carcinoma as a predictive factor for a benefit from accelerated radiation therapy in a randomised controlled trial. Journal of Clinical Oncology , 23 (24) pp. 5560-5567. 10.1200/jco.2005.06.411.

Beresford, M; Ah-See M L, T; N J, S; J J, M; A, DJA; Leach, MO; Padhani, AR; (2005) Inter-and intra-observer variability of DCE-MRI in breast cancer. In:

Beresford, M; Glynne-Jones, R; Richman, P; Makris, A; Mawdsley, S; Stott, D; Harrison, M; ... Harrison, RA; + view all (2005) The reliability of lymph-node staging in rectal cancer after preoperative chemoradiotherapy. CLINICAL ONCOLOGY , 17 (6) pp. 448-455.

Beresford, M; Padhani, AR; Goh, V; Makris, A; (2005) Imaging breast cancer response during neoadjuvant systemic therapy. Expert Review of Anticancer Therapy , 5 (5) pp. 893-905.

Beresford, MJ; Ah-See, M; Daley, F; Richman, P; Harris, A; Makris, A; (2005) The role of the angiogenic marker, endoglin, as a predictor of response to neoadjuvant chemotherapy in primary bresat cancer. In: (pp. S59-S59).

Beresford, MJ; Ah-See, ML; Burcombe, R; Dixon, J; Ostler, P; Harrsion, M; Pittam, R; ... A, ; + view all (2005) Do pre-treatment haemaglobin levels predicct for response to neoadjuvant chemotherapy in breast cancer? In: (pp. 80s-80).

Beresford, MJ; Makris, A; Taylor, NJ; Stirling, JJ; Ah-See, M; d'Arcy, JA; Collins, D; (2005) Observer variability in dynamic contrast-enhanced MRI when used for prediction of response to neoadjuvant chemotherapy in primary breast cancer. In: (pp. S206-).

Bose, F; Fugazza, C; Capelli, A; Ronzoni, L; Cappellini, MD; Jane, S; Cunningham, J; ... Ronchi, A; + view all (2005) Functional interaction of CP2 with GATA-1 in the regulation of the expression of erythroid promoters. In: (Proceedings) 14th Conference on Hemoglobin Switching. (pp. pp. 119-120). ACADEMIC PRESS INC ELSEVIER SCIENCE

Bower, M; Powles, T; Stebbing, J; Thirlwell, C; (2005) Potential antiretroviral drug interactions with cyclophosphamide, doxorubicin, and etoposide. J CLIN ONCOL , 23 (6) 1328 - 1329. 10.1200/JCO.2005.05.128.

Braithwaite, D; Sutton, S; Mackay, J; Stein, J; Emery, J; (2005) Development of a risk assessment tool for women with a family history of breast cancer. Cancer Detection and Prevention , 29 (5) pp. 433-439.

Braybrooke, JP; Slade, A; Deplanque, G; Harrop, R; Madhusudan, S; Forster, MD; Gibson, R; ... Harris, AL; + view all (2005) Phase I study of MetXia-P450 gene therapy and oral cyclophosphamide for patients with advanced breast cancer or melanoma. CLINICAL CANCER RESEARCH , 11 (4) pp. 1512-1520. 10.1158/1078-0432.CCR-04-0155.

Brittan, M.; (2005) Bone marrow cells contribute to tissue regeneration in the intestine and skin. Doctoral thesis , University of London. Green open access
file

Brooks, S; Bownes, P; Lowe, G; Bryant, L; Hoskin, PJ; (2005) Cervical brachytherapy utilizing ring applicator: comparison of standard and conformal loading. International Journal of Radiation Oncology Biology Physics , 63 (3) pp. 934-939.

Brown, P; Marafioti, T; Kusec, R; Banham, A; (2005) The FOXP1 transcription factor is expressed in the majority of follicular lymphomas but is rarely expressed in classical and lymphocyte predominant Hodgkin's lymphoma. JOURNAL OF MOLECULAR HISTOLOGY , 36 (4) pp. 249-256. 10.1007/s10735-005-6521-3.

Buchmueller, KL; Taherbhai, Z; Howard, CM; Bailey, SL; Nguyen, B; O'Hare, C; Hochhauser, D; ... Lee, M; + view all (2005) Design of a hairpin polyamide, ZT65B, for targeting the inverted CCAAT box (ICB) site in the multildrug resistant (MDR1) gene. CHEMBIOCHEM , 6 (12) 2305 - 2311. 10.1002/cbic.200500179.

Burcombe, RJ; Makris, A; Richman, PI; Daley, FM; Noble, S; Pittam, M; Wright, D; ... Wilson, GD; + view all (2005) Evaluation of ER, PgR, HER-2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer. British Journal of Cancer , 92 (1) pp. 147-155.

Burk, K; (2005) George Saintsbury: the Man and His Glass. The World of Fine Wine , None (7) pp. 50-55.

Burton, C; Smith, P; Vaughan-Hudson, G; Qian, W; Hoskin, P; Cunningham, D; Hancock, B; (2005) Comparison of CHOP versus CIOP in good prognosis younger patients with histologically aggressive non-Hodgkin lymphoma. Br J Haematol , 130 (4) pp. 536-541. 10.1111/j.1365-2141.2005.05640.x.

Butcher, LM; Meaburn, E; Dale, PS; Sham, P; Schalkwyk, LC; Craig, IW; Plomin, R; (2005) Association analysis of mild mental impairment using DNA pooling to screen 432 brain-expressed single-nucleotide polymorphisms. Mol.Psychiatry , 10 (4) pp. 384-392. 10.1038/sj.mp.4001589.

Butcher, LM; Meaburn, E; Knight, J; Sham, PC; Schalkwyk, LC; Craig, IW; Plomin, R; (2005) SNPs, microarrays and pooled DNA: identification of four loci associated with mild mental impairment in a sample of 6000 children. Hum.Mol.Genet. , 14 (10) pp. 1315-1325. 10.1093/hmg/ddi142.

C

CHICKEN, DW; FALZON, M; KOCJAN, G; DOUEK, M; SAINSBURY, JRS; KESHTGAR, MRS; (2005) Intraoperative Touch Imprint Cytology of Clinically Apparently Involved Sentinel Node Metastases: Why Bother?. In: (pp. p. 31).

Cairo, S; De Falco, F; Pizzo, M; Salomoni, P; Pandolfi, PP; Meroni, G; (2005) PML interacts with Myc, and Myc target gene expression is altered in PML-null fibroblasts. ONCOGENE , 24 (13) 2195 - 2203. 10.1038/sj.onc.1208338.

Calvert, H; Twelves, C; Ranson, M; Anthoney, A; Plummer, R; Fettner, S; Dayaram, B; ... Rakhit, A; + view all (2005) The effect of erlotinib on CYP3A4 activity, as quantified by the erythromycin breath test and oral midazolam kinetics in cancer patients: Preliminary results. In: JOURNAL OF CLINICAL ONCOLOGY. (pp. 210S - 210S). AMER SOC CLINICAL ONCOLOGY

Camilleri, RS; Cohen, H; (2005) No association between pulmonary embolism or deep vein thrombosis and the -455G/A beta-fibrinogen gene polymorphism. BLOOD COAGUL FIBRIN , 16 (3) 193 - 198.

Capponcelli, S; Pedrini, E; Cerone, MA; Corti, V; Fontanesi, S; Alessio, M; Bachi, A; ... Sangiorgi, L; + view all (2005) Evaluation of the molecular mechanisms involved in the gain of function of a Li-Fraumeni TP53 mutation. Hum Mutat , 26 (2) pp. 94-103. 10.1002/humu.20192.

Cardigan, R; Lawrie, AS; Mackie, IJ; Williamson, LM; (2005) The Quality of Fresh-Frozen Plasma (FFP) Produced from Whole Blood Stored at 4°C Overnight. Transfusion , 45 pp. 1342-1348.

Carroll, VA; Nikitenko, LL; Bicknell, R; Harris, AL; (2005) Antiangiogenic activity of a domain deletion mutant of tissue plasminogen activator containing kringle 2. ARTERIOSCL THROM VAS , 25 (4) 736 - 741. 10.1161/01.ATV.0000157980.15710.2b.

Cerone, MA; Autexier, C; Londoño-Vallejo, JA; Bacchetti, S; (2005) A human cell line that maintains telomeres in the absence of telomerase and of key markers of ALT. Oncogene , 24 (53) pp. 7893-7901. 10.1038/sj.onc.1208934.

Cerone, MA; Ward, RJ; Londoño-Vallejo, JA; Autexier, C; (2005) Telomerase RNA mutated in autosomal dyskeratosis congenita reconstitutes a weakly active telomerase enzyme defective in telomere elongation. Cell Cycle , 4 (4) pp. 585-589.

Chang, JC; Hisenback, SG; Yee, D; Tsimelzon, A; Harrison, M; Gutierrez, CM; Elledge, RM; ... A, ; + view all (2005) Gene expression profiles as predictors of response to neoadjuvant taxotere and adriamycin/cyroxan:a propsective randomized trial in breast cancers. In: (pp. S31-S31).

Charrier, S; Dupre, L; Blundell, M; Scaramuzza, S; Jeanson, L; Vainchenker, W; Danos, O; ... Galy, A; + view all (2005) Functional correction of lymphocytes and dendritic cells of patients with WAS or XLT, using lentiviral vectors targeting the expression of WAS protein to hematopoietic cells. Blood , 106 (11) 852A-852A.

Charrier, S; Stockholm, D; Seye, K; Opolon, P; Taveau, M; Gross, D-A; Bucher-Laurent, S; ... Galy, A; + view all (2005) A lentiviral vector encoding the human Wiskott-Aldrich syndrome protein corrects immune and cytoskeletal defects in WASP knockout mice. Gene Ther , 12 (7) pp. 597-606. 10.1038/sj.gt.3302440.

Chen-Scarabelli, C; Hughes, SE; Landon, G; Rowley, P; Allebban, Z; Lawson, N; Saravolatz, L; ... Scarabelli, TM; + view all (2005) A case of fatal ephedra intake associated with lipofuscin accumulation, caspase activation and cleavage of myofibrillary proteins. EUR J HEART FAIL , 7 (5) 927 - 930. 10.1016/j.ejheart.2004.09.012.

Chester, KA; Baker, M; Mayer, A; (2005) Overcoming the immunologic response to foreign enzymes in cancer therapy. Expert Rev Clin Immunol , 1 (4) pp. 549-559. 10.1586/1744666X.1.4.549.

Cheung, CW; Burton, C; Smith, P; Linch, DC; Hoskin, PJ; Ardeshina, KM; (2005) Central nervous system chemoprophylaxis in non-Hodgkin's lymphoma: A questionnaire-based survey evaluating current practice in the United Kingdom. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 26 - 27). BLACKWELL PUBLISHING

Chicken, DW; Clarke, BR; Johnson, KS; Lee, AC; Briggs, G; Pickard, CDO; Falzon, M; ... Keshtgar, MRS; + view all (2005) Optical biopsy: breast cancer diagnoses at the speed of light. In: BREAST CANCER RESEARCH AND TREATMENT. (pp. S43 - S43). SPRINGER

Chicken, DW; Lee, AC; Johnson, KS; Clarke, B; Falzon, M; Bigio, IJ; Bown, SG; (2005) Elastic scattering spectroscopy for detection of sentinel lymph node metastases in breast carcinoma. Optics InfoBase Conference Papers

Cholongitas, E; Quaglia, A; Samonakis, D; Senzolo, M; Triantos, CK; Patch, D; Dhillon, AP; ... Burroughs, AK; + view all (2005) Transjugular liver biopsy: Is it effective for accurate histological interpretation? In: GUT. (pp. A26 - A26). B M J PUBLISHING GROUP

Clark, BR; Johnson, K; Mackenzie, GD; Novelli, MR; Selvasekar, CR; Thorpe, SM; Bown, SG; ... Bigio, IJ; + view all (2005) In-vivo detection of pre-cancerous changes in Barrett's esophagus using elastic scattering spectroscopy (ESS). In: (Proceedings) SPIE - the International Society for Optical Engineering. (pp. 5862OB-). International Society for Optical Engineering: USA.

Cleator, SJ; Makris, A; Ashley, SE; Lal, R; Powles, TJ; (2005) Good clinical response of breast cancers to neoadjuvant chemoendocrine therapy is associated with improved overall survival. Annals of Oncology , 16 (2) pp. 267-272.

Clingen, P.H.; De Silva, I.U.; McHugh, P.J.; Ghadessy, F.J.; Tilby, M.J.; Thurston, D.E.; Hartley, J.A.; (2005) The XPF-ERCC1 endonuclease and homologous recombination contribute to the repair of minor groove DNA interstrand crosslinks inmammalian cells produced by the pyrrolo[2,1-c][1,4]benzodiazepine dimer SJG-136. Nucleic Acids Research , 33 (10) pp. 3283-3291. 10.1093/nar/gki639. Green open access
file

Clingen, P.H.; De Silva, I.U.; McHugh, P.J.; Ghadessy, F.J.; Tilby, M.J.; Thurston, D.E.; Hartley, J.A.; (2005) The XPF-ERCC1 endonuclease and homologous recombination contribute to the repair of minor groove DNA interstrand crosslinks in mammalian cells produced by the pyrrolo[2,1-c][1,4]benzodiazepine dimer SJG-136. Nucleic Acids Research , 33 (10) pp. 3283-3291. 10.1093/nar/gki639. Green open access
file

Coelho, JJ; Arnold, A; Nayler, J; Tischkowitz, M; Mackay, J; (2005) An assessment of the efficacy of cancer genetic counselling using real-time videoconferencing technology (telemedicine) compared to face-to-face consultations. European Journal of Cancer , 41 (15) pp. 2257-2261.

Cohen, H; (2005) Analysis of the Sliding Window Powering Algorithm. J. Cryptology , 18 (1) pp. 63-76. 10.1007/s00145-004-0218-8.

Cohen, H; (2005) Inherited thrombophilia and pregnancy loss-epidemiology. THROMBOSIS RESEARCH , 115 13 - 17.

Cohen, H; Scully, M; Starke, R; Mackie, I; Machin, S; (2005) Successful pregnancy outcome of three patients with chronic, unremitting Thrombotic Thrombocytopenic Purpura. In: THROMBOSIS RESEARCH. (pp. 116 - 116). PERGAMON-ELSEVIER SCIENCE LTD

Corrie, PG; Shaw, J; Spanswick, VJ; Sehmbi, R; Jonson, A; Mayer, A; Bulusu, R; ... Cree, IA; + view all (2005) Phase I trial combining gemcitabine and treosulfan in advanced cutaneous and uveal melanoma patients. BRIT J CANCER , 92 (11) 1997 - 2003. 10.1038/sj.bjc.6602586.

Corrie, PG; Shaw, J; Spanswick, VJ; Sehmbi, R; Jonson, A; Mayer, A; Bulusu, R; ... Cree, IA; + view all (2005) Phase I trial combining gemcitabine and treosulfan in advanced cutaneous and uveal melanoma patients. British Journal of Cancer , 92 (11) pp. 1997-2003.

Cross, JGR; Harrison, GA; Coggill, P; Sims, S; Beck, S; Deakin, JE; Graves, JAM; (2005) Analysis of the genomic region containing the tammar wallaby (Macropus eugenii) orthologues of MHC class III genes. CYTOGENET GENOME RES , 111 (2) 110 - 117. 10.1159/000086379.

Cutillas, PR; Geering, B; Waterfield, MD; Vanhaesebroeck, B; (2005) Quantification of gel-separated proteins and their phosphorylation sites by LC-MS using unlabeled internal standards: analysis of phosphoprotein dynamics in a B cell lymphoma cell line. Mol Cell Proteomics , 4 (8) pp. 1038-1051. 10.1074/mcp.M500078-MCP200.

D

Damien, E; Causa, F; Ambrosio, L; Revell, PA; (2005) In vivo characterisation of a novel hydrophilic composite for total intervertebral disc substitution. BIOCERAMICS 17 , 284-28 pp. 795-798. 10.4028/www.scientific.net/KEM.284-286.795.

Daniell, K; Stewart, M; Madsen, E; Le, M; Handl, H; Brooks, N; Kiakos, K; ... Lee, M; + view all (2005) Design, synthesis, and biological evaluation of achiral analogs of duocarmycin SA. BIOORG MED CHEM LETT , 15 (1) 177 - 180. 10.1016/j.bmcl.2004.10.021.

Daniell, K; Stewart, M; Madsen, E; Le, M; Handl, H; Brooks, N; Kiakos, K; ... Lee, M; + view all (2005) Design, synthesis, and biological evaluation of achiral analogs of duocarmycin SA. Bioorg Med Chem Lett , 15 (1) pp. 177-180. 10.1016/j.bmcl.2004.10.021.

Davies, DL; Kochegarov, AA; Kuo, S; Kulkarni, AA; Woodward, JJ; King, BF; Arkana, RL; (2005) Ethanol differentially affects ATP-gated P2X<sub>3</sub> and P2X<sub>4</sub> receptor subtypes expressed in <i>Xenopus</i> oocytes. Neuropharmacology , 49 (2) pp. 243-253.

Deakin, JE; Papenfuss, AT; Cross, JGR; Belov, K; Coghill, P; Palmer, S; Sims, S; ... Graves, JAM; + view all (2005) Comparative analysis and evolution of the MHC class III region. In: TISSUE ANTIGENS. (pp. 395 - 395). BLACKWELL PUBLISHING

Dearling, JLJ; Qureshi, U; Begent, RHJ; Pedley, RB; (2005) Radioimmunotherapy Combined with Anti-Hypoxia Therapy 2DG Results in Reduction of Therapeutic Efficacy. In: (pp. S48-S48). SPRINGER

Dearling, JLJ; Qureshi, U; Begent, RHJAPRB; (2005) RIT given in combination with anti-hypoxia therapy 2DG leads to loss of therapeutic efficacy. In: (Proceedings) NCRI cancer Conference Proceedings. (pp. 66-).

Dearling, JLJ; Qureshi, U; Whiting, S; Boxer, G; Begent, RHJAPRB; (2005) Quantitative autoradiography revelas higher antibody uptake in peripheral intrahepatic deposits than in central deposits. In: (Proceedings) NCRI Cancer Conference Proceedings. (pp. 56-).

Dearling, JLJ; Qureshi, U; Whiting, S; Boxer, GM; Begent, RHJ; Pedley, RB; (2005) Analysis of Antibody Distribution Reveals Higher Uptake in Peripheral Intrahepatic Deposits Than Central Deposits. In: (pp. S83-S83). SPRINGER

Deborah, H; (2005) I haven’t smoked for 23 years yet now I face the serves-you-right stigma of this forgotten disease. Evening Standard pp. 27-28.

Diss, TC; Berisha, F; Lam, L; Flanagan, AM; (2005) Detection of Ewing and synovial sarcoma fusion transcripts using conventional and real-time PCR. In: (Proceedings) 94th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology. (pp. 13A-13A). NATURE PUBLISHING GROUP

Diss, TC; Berisha, F; Lam, L; Flanagan, AM; (2005) Detection of Ewing and synovial sarcoma fusion transcripts using conventional and real-time PCR. In: (Proceedings) 94th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology. (pp. 13A-13A). NATURE PUBLISHING GROUP

Diss, TC; Lam, L; Berisha, F; Flanagan, AM; (2005) Detection of Ewing and synovial sarcoma fusion transcripts using conventional and real-time RT-PCR. In: (Proceedings) 3rd Joint Meeting of the British Division of the International-Academy-of-Pahtology/Meeting of the Pathological-Society-of-Great-Britian-and-Ireland. (pp. p. 54). JOHN WILEY & SONS LTD

Diss, TC; Lam, L; Berisha, F; Flanagan, AM; (2005) A real-time RT-PCR method for detection of EWS/ATF1 fusion transcripts in clear cell sarcoma using paraffin-embedded material. In: (Proceedings) 3rd Joint Meeting of the British Division of the International-Academy-of-Pahtology/Meeting of the Pathological-Society-of-Great-Britian-and-Ireland. (pp. p. 53). JOHN WILEY & SONS LTD

Dogan, A; Du, MQ; Isaacson, PG; (2005) A relapsing inflammatory syndrome and HHV-8. NEW ENGLAND JOURNAL OF MEDICINE , 353 (16) p. 1746. Green open access
file

Dudderidge, TJ; Haynes, SVZ; Davies, AJW; Jarmulowicz, M; Al-Akraa, MA; (2005) Vesicocervical fistula: rare complication of cesarean section demonstrated by magnetic resonance imaging. Urology , 65 (1) 174-. 10.1016/j.urology.2004.07.001.

Dudderidge, TJ; Stoeber, K; Loddo, M; Atkinson, G; Fanshawe, T; Griffiths, DF; Williams, GH; (2005) Mcm2, geminin and Ki67 define proliferative state and are predictors of outcome in renal cell carcinoma. Clinical Cancer Research , 11 pp. 2510-2517.

de Bruin, EC; van de Pas, S; Lips, EH; van Eijk, R; van der Zee, MM; Lombaerts, M; van Wezel, T; ... Peltenburg, LT; + view all (2005) Macrodissection versus microdissection of rectal carcinoma: minor influence of stroma cells to tumor cell gene expression profiles. BMC Genomics , 6 , Article 142. 10.1186/1471-2164-6-142. Green open access
file

de Groot, NG; Garcia, CA; Verschoor, EJ; Doxiadis, GGM; Marsh, SGE; Otting, N; Bontrop, RE; (2005) Reduced MIC gene repertoire variation in west African chimpanzees as compared to humans. MOLECULAR BIOLOGY AND EVOLUTION , 22 (6) pp. 1375-1385. 10.1093/molbev/msi127.

E

Edwards, C.S.; (2005) The roles of vaccinia virus proteins in kinesin-dependent microtubule transport. Doctoral thesis , University of London. Green open access
file

El, EE; Dearling, J; Huhalov, A; Neri, D; Begent, RHJ; Pedley, RB; (2005) Targeting tumour vasculature in human colorectal xenografts using against the extra-domain B of fibronectin. In: (Proceedings) NCRI Cancer Conference proceedings.

Enver, T; Huang, S; (2005) Mathematical modeling of transcriptional regulatory circuits defines cell fate attractors and predicts the genome-scale behaviour of haemopoietic progenitor cells undergoing a binary cell fate decision. In: (Proceedings) 47th Annual Meeting of the American-Society-of-Hematology. (pp. 135B-135B). AMER SOC HEMATOLOGY

F

Ffolkes, LV; Agrawal, V; Parkinson, MC; Benjamin, E; (2005) The effects of androgen therapy on the female genital tract. In: MODERN PATHOLOGY. (pp. 183A - 183A). NATURE PUBLISHING GROUP

Ffolkes, LV; Agrawal, V; Parkinson, MC; Benjamin, E; (2005) The effects of androgen therapy on the female genital tract. In: (Proceedings) 94th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology. (pp. 183A-183A). NATURE PUBLISHING GROUP

Field, D; Feil, EJ; Wilson, GA; (2005) Databases and software for the comparison of prokaryotic genomes. Microbiology , 151 (Pt 7) pp. 2125-2132.

Foroni, L; Mitchell, W; Rai, LJ; Casanova, A; Gerrard, G; Patel, B; Richards, S; ... Goldstone, AH; + view all (2005) Molecular monitoring of residual disease (MRD) during induction and intensification phases in low risk adult B cell ALL treated according to the MRC UKALL12 protocol. In: BLOOD. (pp. 423A - 423A). AMER SOC HEMATOLOGY

Foroni, L; Mitchell, W; Rai, LJ; Casanova, A; Patel, B; Richards, S; Fielding, A; (2005) Value of molecular monitoring for minimal residual disease preceding autologous SCT following diagnosis of B cell acute lymphoblastic leukemia in patients treated with the MRC UKALL12 protocol. In: BLOOD. (pp. 423A - 424A). AMER SOC HEMATOLOGY

Foroni, L; Mitchell, W; Rai, LJ; Richards, S; Fielding, A; Goldstone, AH; (2005) The value of molecular monitoring for residual disease (MRD) in early morphological remitters among adults diagnosed with B cell ALL and treated according to the MRC UKALL12 protocol. In: BLOOD. (pp. 423A - 423A). AMER SOC HEMATOLOGY

Forshew, T; Khaliq, S; Tee, L; Smith, U; Johnson, CA; Mehdi, SQ; Maher, ER; (2005) Identification of novel TYR and TYRP1 mutations in oculocutaneous albinism. CLINICAL GENETICS , 68 (2) pp. 182-184. 10.1111/j.1399-0004.2005.00460.x.

G

Gale, RE; Hills, R; Kottaridis, P; Srirangan, S; Wheatley, K; Burnett, A; Linch, DC; (2005) No evidence that FLT3 status should be considered as an indicator for transplantation in acute myeloid leukemia (AML): an analysis of 1135 patients, excluding acute promyelocytic leukemia, from the UK MRC AML10 and 12 trials. Blood , 106 (10) pp. 3658-3665. 10.1182/blood-2005-03-1323.

Gale, RE; Hills, R; Pizzey, AR; Kottaridis, PD; Swirsky, D; Gilkes, AF; Nugent, E; ... Grimwade, DNCRIALWP; + view all (2005) Relationship between FLT3 mutation status, biologic characteristics, and response to targeted therapy in acute promyelocytic leukemia. Blood , 106 (12) pp. 3768-3776. 10.1182/blood-2005-04-1746.

Ganeshaguru, K; Folarin, NI; Baker, RJ; Casanova, AM; Bhimjiyani, A; Hoffbrand, AV; Mehta, AB; (2005) An in vitro model of proliferating CLL cells for drug sensitivity analysis. In: BLOOD. (pp. 829A - 829A). AMER SOC HEMATOLOGY

Gardiner, C; Williams, KE; Mackie, IJ; Machin, SJ; Cohen, H; (2005) A randomised control trial of patient self-management of oral anticoagulation compared with patient self-testing. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 11 - 11). BLACKWELL PUBLISHING

Gardiner, C; Williams, KE; Mackie, IJ; Machin, SJ; Cohen, H; (2005) A randomised controlled trial of patient self management of oral anticoagulation compared with patient self-testing. In: (Proceedings) British society for haematology annual scientific meeting.

Garrett, MD; Mittnacht, S; (2005) Editorial overview: The genetics and biology of cancer - revealing avenues for therapy. CURRENT OPINION IN GENETICS & DEVELOPMENT , 15 (1) pp. 1-4. 10.1016/j.gde.2004.12.012.

Garrett, MD; Mittnacht, S; (2005) Editorial overview: The genetics and biology of cancer - revealing avenues for therapy. CURRENT OPINION IN GENETICS & DEVELOPMENT , 15 (1) pp. 1-4. 10.1016/j.gde.2004.12.012.

Gerrard, G; Butters, TD; Ganeshaguru, K; Mehta, A; (2005) Glucosylceramide synthase inhibitors sensitise CLL cells to cytotoxic agents without reversing P-gp functional activity. European Journal of Pharmacology , 609 (1-3) pp. 34-39.

Ginsberg, L; Valentine, A; Mehta, A; (2005) Neurological rarity - Fabry disease. Practical Neurology , 5 (2) pp. 110-113. 10.1111/j.1474-7766.2005.00275.x.

Glasow, A; Barrett, A; Gupta, R; Grimwade, D; von Lindern, M; Enver, T; Zelent, A; (2005) Expression of ATRA inducible RAR alpha 2 isoform is deregulated in AML. In: (Proceedings) 47th Annual Meeting of the American-Society-of-Hematology. (pp. 351A-351A). AMER SOC HEMATOLOGY

Glassford, J; Brosens, JJ; Turner, M; Lam, EWEA; (2005) Phosphatidylinositol 3-kinase is required for the transcriptional activation of cyclin D2 in BCR activated primary mouse B lymphocytes. European Journal of Immunology , 95 (9) pp. 2748-2761.

Gomez, K; McVey, JH; Tuddenham, E; (2005) Inhibition of coagulation by macromolecular complexes. Haematologica , 90 (11) pp. 1570-1576. Gold open access

Gomez-Escobar, N; Bennett, C; Prieto-Lafuente, L; Aebischer, T; Blackburn, CC; Maizels, RM; (2005) Heterologous expression of the filarial nematode alt gene products reveals their potential to inhibit immune function. BMC Biology , 3 , Article 108. 10.1186/1741-7007-3-8. Green open access
file

Grandage, VL; Linch, DC; Khwaja, A; (2005) Go6976 is a novel and potent inhibitor of JAK2 and JAK3 tyrosine kinases both in vitro and in cellular assays. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 6 - 6). BLACKWELL PUBLISHING

Grandage, VL; Linch, DC; Khwaja, A; (2005) Go6976, a novel and potent inhibitor of JAK2 and JAK3, reduces constitutive STAT activity and induces apoptosis in myeloid leukaemia and anaplastic lymphoma cells. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 40 - 40). BLACKWELL PUBLISHING

Guérardel, A; Barat-Houari, M; Vasseur, F; Dina, C; Vatin, V; Clément, K; Eberlé, D; ... Froguel, P; + view all (2005) Analysis of sequence variability in the CART gene in relation to obesity in a Caucasian population. BMC Genet , 6 19-. 10.1186/1471-2156-6-19. Gold open access

H

Hackshaw, AK; (2005) Passive smoking; what is it and why is it harmful? In: Britton, J and Edwards, R, (eds.) Going smoke-free: the medical case for clean air in the home, at work and in public places. A report on passive smoking of the Tobacco Advisory Group of the Royal College of Physicians. (pp. 1-11). Royal College of Physicians

Hackshaw, AK; Knight, A; Barrett-Lee, P; Leonard, R; (2005) Surrogate markers and survival in women receiving first-line combination anthracycline chemotherapy for advanced breast cancer. BRITISH JOURNAL OF CANCER , 93 (11) pp. 1215-1221. 10.1038/sj.bjc.6602858.

Haines, BP; Gupta, R; Jones, CM; Summerbell, D; Rigby, PW; (2005) The NLRR gene family and mouse development: Modified differential display PCR identifies NLRR-1 as a gene expressed in early somitic myoblasts. Developmental Biology , 281 (2) pp. 145-159. 10.1016/j.ydbio.2005.01.030.

Harish, S; Saifuddin, A; Cannon, SR; Flanagan, AM; (2005) Synovial chondromatosis of the foot presenting with Lisfranc dislocation. Skeletal Radiol , 34 (11) pp. 736-739. 10.1007/s00256-005-0923-x.

Harlaar, N; Butcher, LM; Meaburn, E; Sham, P; Craig, IW; Plomin, R; (2005) A behavioural genomic analysis of DNA markers associated with general cognitive ability in 7-year-olds. J.Child Psychol.Psychiatry , 46 (10) pp. 1097-1107. 10.1111/j.1469-7610.2005.01515.x.

Harney, J.A.; (2005) An investigation of low dose hyper-radiosensitivity - Does it have a role clinically? Doctoral thesis , University of London. Green open access
file

Harris, C; Hughes, D; Budge, F; Mehta, A; (2005) SACCADIC EYE MOVEMENTS IN D409H-N370S GAUCHER HETEROZYGOTES. Presented at: UNSPECIFIED.

Harrison, CN; et, A; (2005) Hydroxyurea compared with anegralide in high risk essential thrombocythaemia. New England Journal of Medicine , 353 (1) pp. 33-45.

Hartley, JA; Hochhauser, D; Lee, M; Howard, PW; Thurston, DE; (2005) DNA targeting with PBD and polyamide-based agents. In: CLINICAL CANCER RESEARCH. (pp. 9176S - 9176S). AMER ASSOC CANCER RESEARCH

Hartmann, G; Vassileva, V; Piquette-Miller, M; (2005) Impact of endotoxin-induced changes in P-glycoprotein expression on disposition of doxorubicin in mice. DRUG METABOLISM AND DISPOSITION , 33 (6) pp. 820-828. 10.1124/dmd.104.002568.

Hoffmann, B; Garcia, DLA; Mehta, A; Beck, M; Widmer, U; Ricci, RFOSEI; (2005) Effects of enzyme replacement therapy on pain and health related quality of life in patients with Fabry disease: data from FOS (Fabry Outcome Survey). Journal of Medical Genetics , 42 (3) pp. 247-242.

Hoskin, PJ; (2005) Palliative radiotherapy for non-small-cell lung cancer: Which dose? ELSEVIER SCIENCE LONDON, 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND

Hoskin, PJ; (2005) Radioisotopes for metastatic bone pain. LANCET LTD, 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND

Hoskin, PJ; (2005) Evaluation and mangement of the patient with bone metastases at presentation. In: Claude, JE and Rodolfo, CE and Lawrence, CE and Robert, CE and Gerard, S, (eds.) Textbook of Bone Metastases. (pp. 545-554). John Wiley & Sons

Hoskin, PJ; (2005) Overview of treatment.Cancer Pain. In: Stephen, MMK, (ed.) Wall & Melzac's Textbook of Pain. Churchill Livingstone

Hoskin, PJ; Ahmedzai, S; Muers, MF; (2005) Assessment and management of respiratory symptoms of malignant disease. In: Ahmedzai, S and Muers, MF, (eds.) Supportive care in respiratory disease. (pp. 463-486). Oxford University Press

Hoskin, PJ; Rojas, AM; Phillips, H; Saunders, MI; (2005) Acute and late morbidity in the treatment of advanced bladder carcinoma with accelerated radiotherapy, carbogen, and nicotinamide. Cancer , 103 (11) pp. 2287-2297. 10.1002/cncr.21048.

Hoskin, PJ; Smith, P; Maughan, TS; Gilson, D; Vernon, C; Syndikus, I; Linch, DC; (2005) Long-term results of a randomised trial of involved field radiotherapy vs extended field radiotherapy in stage I and II Hodgkin lymphoma. Clinical Oncology , 17 (1) pp. 47-53. 10.1016/j.clon.2004.07.004.

Hoskin, PJ; Smith, P; Maughan, TS; Gilson, D; Vernon, C; Syndikus, I; Linch, DC; (2005) Long-term results of a randomised trial of involved field radiotherapy vs extended field radiotherapy in stage I and II Hodgkin lymphoma. CLIN ONCOL-UK , 17 (1) 47 - 53. 10.1016/j.clon.2004.07.004.

Hughes, D; Baker, R; Richfield, L; Milligan, A; Goodwin, S; Blincoe, M; Bruce, R; (2005) BALANCED ORAL SUBSTRATE REDUCTION THERAPY FOR PATIENTS WITH MILD TO MODERATE GAUCHER DISEASE: ONE YEAR IN CLINICAL PRACTICE. Presented at: UNSPECIFIED.

Hughes, DA; Mehta, AB; (2005) Vascular complications of Fabry disease: enzyme replacement and other therapies. Acta Paediatr Suppl , 94 (447) pp. 28-33.

Hunter, HM; Peggs, K; Powles, R; Rahemtulla, A; Mahendra, P; Cavenagh, J; Littlewood, T; ... Clinical Trials Comm British Soc, ; + view all (2005) Analysis of outcome following allogeneic haemopoietic stem cell transplantation for myeloma using myeloablative conditioning - evidence for a superior outcome using melphalan combined with total body irradiation. BRIT J HAEMATOL , 128 (4) 496 - 502. 10.1111/j.1365-2141.2004.05330.x.

I

Izawa, D; Goto, M; Yamashita, A; Yamano, H; Yamamoto, M; (2005) Fission yeast Mes1p ensures the onset of meiosis II by blocking degradation of cyclin Cdc13p. Nature , 434 (7032) pp. 529-533.

J

Jalal, H; Bibby, DF; Tang, JW; Bennett, J; Kyriakou, C; Peggs, K; Cubitt, D; ... Tedder, RS; + view all (2005) First reported outbreak of diarrhea due to adenovirus infection in a hematology unit for adults. J CLIN MICROBIOL , 43 (6) 2575 - 2580. 10.1128/JCM.43.6.2575-2580.2005.

Jenny, C; Toublanc, E; Danos, O; Merten, O-W; (2005) Evaluation of a Serum-free Medium for the Production of rAAV-2 using HeLa Derived Producer Cells. Cytotechnology , 49 (1) pp. 11-23. 10.1007/s10616-005-5361-z.

Jewell, AP; Cochrane, M; McIntosh, J; Benjamin, R; Nathwani, A; (2005) Comparison of viral vectors for gene transfer into CLL cells: Efficient transduction with adeno-associated virus-8 (AAV-8). In: BLOOD. (pp. 837A - 837A). AMER SOC HEMATOLOGY

Jonathan, C-B; (2005) Freezing used to kill cancer cells. The Sunday Times

K

Kelly, CMA; Lee, SM; Steele, JP; (2005) Neoadjuvant chemotherapy for non-small cell lung cancer. In: Andrew, M, (ed.) Key Advances in Lung Cancer. (pp. 67-74). Aesculapius Medical Press: London, San Franscisco and Sydney.

Kendall, AH; Williams, GH; Stoeber, K; Salter, J; Dowsett, M; (2005) Effect of estrogen deprivation on proliferation marker Ki-67 and minichromosome maintenance protein-2 (Mcm-2) in normal postmenopausal breast tissue: potential biomarkers for chemoprevention. In: BREAST CANCER RESEARCH AND TREATMENT. (pp. S172 - S172). SPRINGER

Keshtgar, MRS; Chicken, DW; Lee, AC; Briggs, GM; Johnson, KS; Clark, B; Pickard, CDO; ... Bown, SG; + view all (2005) Optical biopsy for real-time diagnosis, staging and prognostication. In: (pp. 452-).

Kim, JB; Price, RK; Stein, RC; O'Hare, MJ; (2005) Risks of the complementary medicine Rhodiola rosea in breast cancer. In: (pp. 3048S-3049S).

Kim, JB; Price, RK; Stein, RC; O'Hare, MJ; (2005) The risks of complementary medicine use (Rhodiola rosea) in breast cancer. In: (pp. 2698S-2698S).

Kim, JB; Stein, RC; O'Hare, MJ; (2005) Development of a fully "humanized" xenograft model of breast cancer - New ideas for the development of pre-clinical prevention models. International Journal of Cancer Prevention , 2 (2) pp. 87-107.

Kleinert, J; Dehout, F; Schwarting, A; de, LAG; Ricci, R; Kampmann, C; Beck, M; ... Sunder-Plassmann, G; + view all (2005) Anemia is a new complication in Fabry disease: data from the Fabry Outcome Survey. Kidney International , 67 (5) pp. 1955-1960.

Knock, J; Shah, M; Wyatt, J; Dixon, M; Casali, G; Lewis, F; Martin, I; ... Grabsch, H; + view all (2005) MCM proteins and geminin in gastric cancer: Association with prognosis, histological type, DNA ploidy and proliferation. In: JOURNAL OF PATHOLOGY. (pp. 8 - 8). JOHN WILEY & SONS LTD

Knowles, S; Milkins, C; Stainsby, D; Jones, H; Cohen, H; (2005) Haemolytic transfusion reactions - how many are preventable? In: (Proceedings) British society for haematology annual scientific meeting.

Kogelberg, H; Tolner, B; Lowdell, M; Qureshi, U; Robson, M; Dearling, JL; Pedley, RB; ... Chester, KA; + view all (2005) Mechansims of clearance of the antibody-directed enzyme prodrug therapeutic, the mannosylated MFE-CP. In: (Proceedings) NCRI Cancer Conference Proceedings.

Koonrugsa, N.; (2005) The role of fission yeast microtubule associated protein, Alp14, in microtubule stabilisation and spindle assembly checkpoint maintenance. Doctoral thesis , University of London. Green open access
file

Kotecha, M; O'Hare, C; Wells, G; Howard, P; Thurston, D; Mantovani, R; Hartley, JA; (2005) Inhibition of DNA binding of the transcription factor complex NF-Y by a pyrrolobenzodiazepine-polyamide conjugate. In: CLINICAL CANCER RESEARCH. (pp. 9016S - 9016S). AMER ASSOC CANCER RESEARCH

Krause, M; Wohlfarth, J; Georgi, B; Pimentel, N; Dorner, D; Zips, D; Eicheler, W; ... Baumann, M; + view all (2005) Low-dose hyperradiosensitivity of human glioblastoma cell lines in vitro does not translate into improved outcome of ultrafractionated radiotherapy in vivo. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY , 81 (10) pp. 751-758.

Kristeleit, R; Fong, P; Aherne, GW; de Bono, J; (2005) Histone deacetylase inhibitors: emerging anticancer therapeutic agents? Clin Lung Cancer , 7 Supp S19-S30.

Kroger, N; Shaw, B; Iacobelli, S; Zabelina, T; Peggs, K; Shimoni, A; Nagler, A; ... Marks, D; + view all (2005) Comparison between anti-thymocyte globulin and alemtuzumab and the possible impact of KIR-ligand mismatch in melphalan/fludarabine dose-reduced conditioning followed by HLA-matched and mismatched unrelated SCT in patients with multiple myeloma. In: BONE MARROW TRANSPLANTATION. (pp. S49 - S49). NATURE PUBLISHING GROUP

Krutzfeldt, M; Ellis, M; Weekes, DB; Bull, JJ; Eilers, M; Vivanco, MDM; Sellers, WR; (2005) Selective ablation of retinoblastoma protein function by the RET finger protein. MOLECULAR CELL , 18 (2) pp. 213-224. 10.1016/j.molcel.2005.03.009.

Kulkarni, S; Davies, AJW; Treurnicht, K; Dudderidge, TJ; Al-Akraa, M; (2005) Misplaced Macroplastique injection presenting as a vaginal nodule and a bladder mass. INT J CLIN PRACT , 59 85 - 86.

Kyriakou, C; Attygalle, A; Linch, D; Goldstone, A; Smith, P; Dogan, A; (2005) Angioimmunoblastic T-cell lymphoma: A large series outcome analysis. In: (Proceedings) 47th Annual Meeting of the American-Society-of-Hematology. (pp. 787A-788A). AMER SOC HEMATOLOGY

L

Lam, L; Diss, TC; Berisha, F; Idowu, BD; Gale, RE; Flanagan, AM; (2005) Differentiation between clear cell sarcoma and malignant melanoma using a molecular approach. In: JOURNAL OF PATHOLOGY. (pp. 5 - 5). JOHN WILEY & SONS LTD

Laman, H; Funes, JM; Ye, H; Henderson, S; Galinanes-Garcia, L; Hara, E; Knowles, P; ... Boshoff, C; + view all (2005) Transforming activity of Fbxo7 is mediated specifically through regulation of cyclin D/cdk6. The EMBO journal , 24 (17) pp. 3104-3116.

Laman, H; Funes, JM; Ye, HT; Henderson, S; Galinanes-Garcia, L; Hara, E; Knowles, P; ... Boshoff, C; + view all (2005) Transforming activity of Fbxo7 is mediated specifically through regulation of cyclin D/cdk6. EMBO J , 24 (17) 3104 - 3116. 10.1038/sj.emboj.7600775.

Laurence, AD; Peggs, KS; (2005) Cerebral and pulmonary nocardia in a bone marrow transplant patient. Br J Haematol , 129 (6) 711-. 10.1111/j.1365-2141.2005.05474.x.

Ledermann, JA; Frickhofen, N; Wandt, H; Bengala, C; Champion, K; Hinke, A; Moebus, V; (2005) A phase III randomised trial of sequential high dose chemotherapy (HDC) with peripheral blood stem cell support or standard dose chemotherapy (SDC) for first-line treatment of ovarian cancer. In: JOURNAL OF CLINICAL ONCOLOGY. (pp. 456S - 456S). AMER SOC CLINICAL ONCOLOGY

Little, AM; Clever, S; Torres, HM; Marsh, SGE; Bronwen, S; Madrigal, A; (2005) Donor factors influencing unrelated volunteer donor selection for haematopoietic stem cell transplantation. In: (Proceedings) Joint Meeting of the American-Society-for-Blood-and-Marrow-Transplantation/Center-for-International-Blood-and-Marrow-Transplant-Research. (pp. p. 52). CARDEN JENNINGS PUBL CO LTD

Little, AM; Marsh, SGE; Madrigal, JA; (2005) Histocompatibilty. In: Postgraduate Haematology. (pp. 395-418). Blackwell Publishing: Oxford.

Lovat, LB; Jamieson, NF; Novelli, MR; Mosse, A; Selvasekar, C; Thorpe, S; Bown, SG; (2005) Photodynamic therapy with mTHPC for high grade dysplasia and early cancer in Barrett’s columnar lined oesophagus. Gastrointestinal Endoscopy , 62 pp. 617-623.

M

Macbeth, F; Stephens, R; Hoskin, P; (2005) Radiation dose in spinal cord compression. UNSPECIFIED

Mackenzie, G; Selvasekar, C; Clark, BR; Novelli, M; Thorpe, S; Mosse, C; Bown, S; (2005) Randomised controlled trial of photodynamic therapy using low dose 5 aminolevulinic acid activated by red or green light for high grade dysplasia in Barrett's esophagus. In: GASTROENTEROLOGY. (pp. A238 - A238). W B SAUNDERS CO

Mackenzie, GD; Clark, B; Selvasekar, CR; Jamieson, NF; Novelli, MR; Thorpe, SM; Masse, CA; ... Lovat, LB; + view all (2005) Photodynamic therapy with 5 aminolevulinic acid for high grade dysplasia in Barrett's oesophagus: Long term follow up of 51 patients. In: GUT. (pp. A15 - A15). B M J PUBLISHING GROUP

Mackenzie, GD; Johnson, K; Novelli, MR; O'Donovan, M; Davies, S; Selvasekar, C; Thorpe, S; ... Lovat, LB; + view all (2005) Optical biopsy using elastic scattering spectroscopy can detect dysplasia and cancer in Barrett's oesophagus. In: GUT. (pp. A15 - A15). B M J PUBLISHING GROUP

Makris, A; (2005) Report on the 9th International conference on primary therapy of early breast cancer. (Breast Cancer Forum , pp. pp. 2-6 ).

Makris, A; (2005) Tamoxifen and exemestane:to switch or not to switch? UNSPECIFIED

Makris, A; Hisenbeck, SG; Yee, D; Osborne, KC; Elledge, RM; Harrison, M; Ostler, PJ; ... Chang, JC; + view all (2005) A prospective randomized multicenter gene expression study of docetaxel vs doxorubicin/cyclophosphamide preoperative trial in primary breast cancers. In: (pp. 14S-14S).

Manoussaka, MS; Memon, A; Nathwani, A; Porakishvili, N; Clark, E; Lydyard, PM; (2005) Toll like receptors (TLRs) in B cell chronic lymphocytic leukemia (B-CLL). In: BLOOD. (pp. 326B - 326B). AMER SOC HEMATOLOGY

Marelli, L; Stigliano, R; Triantos, C; Senzolo, M; Cholongitas, E; Davies, N; Tibballs, J; ... Burroughs, AK; + view all (2005) Transarterial therapy for hepatocellular carcinoma (HCC) in cirrhosis: Is embolisation as effective as chemoembolisation? Systematic review of cohort and randomized studies. In: (Proceedings) 56th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases. (pp. 384A-384A). JOHN WILEY & SONS INC

Marie-Egyptienne, DT; Cerone, MA; Londoño-Vallejo, JA; Autexier, C; (2005) A human-Tetrahymena pseudoknot chimeric telomerase RNA reconstitutes a nonprocessive enzyme in vitro that is defective in telomere elongation. Nucleic Acids Res , 33 (17) pp. 5446-5457. 10.1093/nar/gki848.

Marks, D; Oukrif, D; Novelli, M; Forbes, A; Segal, AW; Harbord, M; (2005) Impaired acute inflammation in the terminal ileum of Crohn's patients. In: GUT. (pp. A37 - A38). B M J PUBLISHING GROUP

Marsh, SGE; (2005) Nomenclature for factors of the HLA system, update August 2005. Int J Immunogenet , 32 (6) pp. 429-430. 10.1111/j.1744-313X.2005.00555.x.

Marsh, SGE; (2005) Nomenclature for factors of the HLA system, update February 2005. Int J Immunogenet , 32 (3) 215-. 10.1111/j.1744-313X.2005.00518.x.

Marsh, SGE; (2005) Nomenclature for factors of the HLA system, update January 2005. Int J Immunogenet , 32 (3) pp. 213-214. 10.1111/j.1744-313X.2005.00517.x.

Marsh, SGE; (2005) Nomenclature for factors of the HLA system, update June 2005. TISSUE ANTIGENS , 66 (4) pp. 338-340. 10.1111/j.1399-0039.2005.00479.x.

Marsh, SGE; (2005) Nomenclature for factors of the HLA system, update March 2005. Int J Immunogenet , 32 (3) pp. 217-218. 10.1111/j.1744-313X.2005.00520.x.

Marsh, SGE; (2005) Nomenclature for factors of the HLA system, update October 2004. Int J Immunogenet , 32 (1) 71-. 10.1111/j.1744-313X.2005.00492.x.

Marsh, SGE; (2005) Nomenclature for factors of the HLA system, update September 2005. Int J Immunogenet , 32 (6) pp. 431-432. 10.1111/j.1744-313X.2005.00556.x.

Marsh, SGE; (2005) Nomenclature for factors of the HLA system, updated July 2005. Int J Immunogenet , 32 (6) pp. 425-428. 10.1111/j.1744-313X.2005.00544.x.

Marsh, SGE; Albert, ED; Bodmer, WF; Bontrop, RE; Dupont, B; Erlich, HA; Geraghty, DE; ... Trowsdale, J; + view all (2005) Nomenclature for Factors of the HLA System, 2004. Human Immunology , 66 pp. 571-636.

Marsh, SGE; Albert, ED; Bodmer, WF; Bontrop, RE; Dupont, B; Erlich, HA; Geraghty, DE; ... Trowsdale, J; + view all (2005) Nomenclature for factors of the HLA system, 2004. International Journal of Immunogenetics , 32 pp. 107-159.

Marsh, SGE; WHO Nomenclature Committee, ; (2005) Nomenclature for factors of the HLA system, update August 2004. Hum Immunol , 66 (1) 92-. 10.1016/j.humimm.2004.10.011.

Marsh, SGE; WHO Nomenclature Committee, ; (2005) Nomenclature for factors of the HLA system, update September 2004. Hum Immunol , 66 (1) 93-. 10.1016/j.humimm.2004.10.012.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2005) Nomenclature for factors of the HLA System, update December 2004. Hum Immunol , 66 (3) pp. 329-330. 10.1016/j.humimm.2005.01.016.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2005) Nomenclature for factors of the HLA System, update November 2004. Hum Immunol , 66 (3) 328-. 10.1016/j.humimm.2005.01.015.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2005) Nomenclature for factors of the HLA System, update October 2004. Hum Immunol , 66 (3) pp. 326-327. 10.1016/j.humimm.2005.01.014.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2005) Nomenclature for factors of the HLA system, update April 2005. Int J Immunogenet , 32 (5) pp. 325-326. 10.1111/j.1744-313X.2005.00527.x.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2005) Nomenclature for factors of the HLA system, update April 2005. Hum Immunol , 66 (9) pp. 1019-1021. 10.1016/j.humimm.2005.10.003.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2005) Nomenclature for factors of the HLA system, update December 2004. Tissue Antigens , 65 (3) pp. 299-300. 10.1111/j.1399-0039.2005.00377.x.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2005) Nomenclature for factors of the HLA system, update February 2005. Hum Immunol , 66 (9) pp. 1015-1016. 10.1016/j.humimm.2005.10.013.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2005) Nomenclature for factors of the HLA system, update January 2005. Hum Immunol , 66 (9) pp. 1013-1014. 10.1016/j.humimm.2005.10.012.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2005) Nomenclature for factors of the HLA system, update July 2005. Hum Immunol , 66 (11) pp. 1183-1186. 10.1016/j.humimm.2005.10.006.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2005) Nomenclature for factors of the HLA system, update June 2005*. Int J Immunogenet , 32 (5) pp. 329-331. 10.1111/j.1744-313X.2005.00535.x.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2005) Nomenclature for factors of the HLA system, update June 2005. Hum Immunol , 66 (9) pp. 1025-1027. 10.1016/j.humimm.2005.10.005.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2005) Nomenclature for factors of the HLA system, update March 2005. Hum Immunol , 66 (9) pp. 1017-1018. 10.1016/j.humimm.2005.10.014.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2005) Nomenclature for factors of the HLA system, update May 2005*. Int J Immunogenet , 32 (5) pp. 327-328. 10.1111/j.1744-313X.2005.00531.x.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2005) Nomenclature for factors of the HLA system, update May 2005. Hum Immunol , 66 (9) pp. 1022-1024. 10.1016/j.humimm.2005.10.004.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2005) Nomenclature for factors of the HLA system, update November 2004. Tissue Antigens , 65 (2) pp. 208-209. 10.1111/j.1399-0039.2005.00366.x.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2005) Nomenclature for factors of the HLA system, update October 2004. Tissue Antigens , 65 (2) pp. 206-207. 10.1111/j.1399-0039.2005.00357.x.

Mawdsley, S; Glynne-Jones, R; Grainger, J; Richman, P; Makris, A; Harrison, M; Ashford, R; ... Wallace, M; + view all (2005) Can histopathologic assessment of circumferential margin after preoperative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for 3-year disease-free survival? International Journal of Radiation Oncology Biology Physics , 63 (3) pp. 745-752.

Mawdsley, S.K.V.; (2005) The prognostic and therapeutic significance of biological molecular markers in human anorectal carcinomas treated with 5'fluorouracil chemoradiation. Doctoral thesis , University of London. Green open access
file

Mayor, NP; Cox, ST; McWhinnie, AJ; Arguello, JR; Shaw, BE; Little, AM; Madrigal, JA; (2005) Sequence of a novel HLA-A*0301 intronic variant (A*03010103). TISSUE ANTIGENS , 65 (1) 107 - 109. 10.1111/j.1399-0039.2004.00340.x.

Mayor, NP; Cox, ST; McWhinnie, AJ; Argüello, JR; Shaw, BE; Little, A-M; Madrigal, JA; (2005) Sequence of a novel HLA-A*0301 intronic variant (A*03010103). Tissue Antigens , 65 (1) pp. 107-109. 10.1111/j.1399-0039.2005.00340.x.

McCabe, DJH; Harrison, P; Mackie, IJ; Sidhu, PS; Lawrie, AS; Purdy, G; Machin, SJ; (2005) Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA. PLATELETS , 16 (5) 269 - 280. 10.1080/09537100400020567.

McMahon, K; Hadjur, S; Menzel, U; Kioussis, D; Brady, HJM; (2005) Elucidating the role of MLL in adult murine haematopoiesis. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 10 - 10). BLACKWELL PUBLISHING

McTiernan, A; Meyer, T; Michelagnoli, MP; Lewis, I; Whelan, JS; (2005) A phase I/II study of doxorubicin, ifosfamide, etoposide and interval methotrexate in patients with poor prognosis osteosarcoma. Pediatric Blood and Cancer , 46 (3) pp. 345-350.

Meaburn, E; Butcher, LM; Liu, L; Fernandes, C; Hansen, V; Al-Chalabi, A; Plomin, R; ... Schalkwyk, LC; + view all (2005) Genotyping DNA pools on microarrays: tackling the QTL problem of large samples and large numbers of SNPs. BMC Genomics , 6 , Article 52. 10.1186/1471-2164-6-52. Green open access
file

Mehta, A; Cassiman, JJ; (2005) The pathophysiology of Fabry Disease. Acta Paediatrica , 94 (447) 79-.

Mehta, AB; Cassiman, JJ; (2005) Understanding genotype-phenotype correlations. Acta Paediatrica , 94 (447) 79-.

Mellidez, JC; Mackenzie, G; Selvasekar, C; Novelli, M; Thorpe, S; Mosse, C; Bown, S; (2005) Reversal of Barrett's esophagus following photodynamic therapy using high dose 5 aminolevulinic acid activated by red or green laser light. In: GASTROENTEROLOGY. (pp. A239 - A239). W B SAUNDERS CO

Miller, RF; Scully, M; Cohen, H; Roedling, S; Starke, R; Edwards, SG; Machin, S; (2005) Thrombotic thrombocytopaenic purpura in human immunodeficiency virus infected patients. International Journal of STD and AIDS , 16 pp. 538-542.

Misteli, T; Scaffidi, P; (2005) Genome instability in progeria: when repair gets old. Nature Medicine , 11 (7) pp. 718-719. 10.1038/nm0705-718.

Moorman, AV; Harrison, CJ; Richards, SM; Fielding, A; Tallman, MS; Litzow, MR; Rowe, JM; ... Dewald, GW; + view all (2005) Karyotype is an independent prognostic factor in adult acute lymphoblastic leukaemia (ALL): Analysis of cytogenetic data from 1,235 patients on the medical research council (MRC) UKALLXII/Eastern cooperative oncology group (ECOG) 2993 trial. In: (Proceedings) 47th Annual Meeting of the American-Society-of-Hematology. (pp. 100A-100A). AMER SOC HEMATOLOGY

Mulholland, PJ; Thirlwell, C; Brock, CS; Newlands, ES; (2005) Emerging targeted treatments for malignant glioma. Expert Opin Emerg Drugs , 10 (4) pp. 845-854. 10.1517/14728214.10.4.845.

Murrell, A; Rakyan, VK; Beck, S; (2005) From genome to epigenome. HUM MOL GENET , 14 R3 - R10. 10.1093/hmg/ddi110.

N

Nacheva, E; Brazma, D; Foroni, L; Grace, C; (2005) A genome wide screening for genetic imbalances of CML by array CGH. In: (Proceedings) 34th Annual Meeting of the International-Society-for-Experimental-Hematology. (pp. p. 59). ELSEVIER SCIENCE INC

Narat, S; Gandla, J; Dogan, A; Mehta, A; (2005) Successful treatment of hairy cell leukemia variant with rituximab. Leukemia and Lymphoma , 48 (8) pp. 1229-1232.

Narat, S; Gandla, J; Hoffbrand, AV; Hughes, RG; Mehta, AB; (2005) Rituximab in the treatment of refractory autoimmune cytopenias in adults. Haematologica , 90 (9) pp. 1273-1274. Gold open access

Nathwani, AC; Davidoff, AM; Linch, DC; (2005) A review of gene therapy for haematological disorders. British Journal of Haematology , 128 (1) pp. 3-17. 10.1111/j.1365-2141.2004.05231.x.

Nathwani, AC; Davidoff, AM; Linch, DC; (2005) A review of gene therapy for haematological disorders. Br J Haematol , 128 (1) pp. 3-17. 10.1111/j.1365-2141.2004.05231.x.

Nathwani, AC; McIntosh, J; Davidoff, AM; (2005) An update on gene therapy for hemophilia. Current hematology reports. , 4 (4) pp. 287-293.

Nathwani, AC; McIntosh, J; Davidoff, AM; (2005) An update on gene therapy for hemophilia. Curr Hematol Rep , 4 (4) pp. 287-293.

Nebot, M; López, MJ; Gorini, G; Neuberger, M; Axelsson, S; Pilali, M; Fonseca, C; ... Centrich, FAHSK; + view all (2005) Environmental tobacco smoke exposure in public places of European cities. Tobacco Control , 14 pp. 60-63.

Nicholls, BM; Bredius, RGM; Hamdy, NAT; Gerritsen, EJA; Lankester, AC; Hogendoorn, PCW; Nesbitt, SA; ... Flanagan, AM; + view all (2005) Limited rescue of osteoclast-poor osteopetrosis after successful engraftment by cord blood from an unrelated donor. Journal of Bone and Mineral Research , 20 (12) pp. 2264-2270. 10.1359/JBMR.050807.

Nicholls, BM; Bredius, RGM; Hamdy, NAT; Gerritsen, EJA; Lankester, AC; Hogendoorn, PCW; Nesbitt, SA; ... Flanagan, AM; + view all (2005) Limited rescue of osteoclast-poor osteopetrosis after successful engraftment by cord blood from an unrelated donor. J BONE MINER RES , 20 (12) 2264 - 2270. 10.1359/JBMR.050807.

Norman, MW; Simpson, M; Mogensen, J; Shaw, A; Hughes, S; Sen-Chowdhry, S; Rowland, E; ... McKenna, WJ; + view all (2005) A novel mutation in desmoplakin causes arrhythmogenic left ventricular cardiomyopathy. Circulation , 112 (5) pp. 636-642. Green open access
file

O

O'Brien, F; Sekhavat, M; Lowdell, M; (2005) Long-term storage of cryopreserved autologous bone marrow retains viable haematopoietic progenitor cells. In: (Proceedings) 31st Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/21st Meeting of the EBMT-Nurses-Group/4th Meeting of the EBMT-Data-Management-Group. (pp. S110-S110). NATURE PUBLISHING GROUP

Oses-Prieto, JA; Joubel, A; Rodriguez-Viciana, P; Fried, M; Burlingame, AL; (2005) Use of crosslinking and tandem affinity purification (TAP) methodology to identify new interaction partners of the kinase Mst-2. In: FASEB JOURNAL. (pp. A1397 - A1397). FEDERATION AMER SOC EXP BIOL

P

Padhani, AR; Ah-See, ML; Makris, A; (2005) MRI in the detection and management of breast cancer. Expert review of anticancer therapy , 5 (2) pp. 239-252.

Padhani, AR; Ah-See, ML; Taylor, NJ; Stirling, JJ; Daley, FM; Richamn, PI; d'Arcy, JA; ... Makris, A; + view all (2005) MRI correlates of tumour grade and hypoxia status in human breast cancer. In:

Pallis, M; Truran, L; Grundy, M; Fisher, J; Hills, R; Moorman, A; Hoy, T; ... Russell, NBA; + view all (2005) Functional p-glycoprotein and internal tandem duplications of FLT3 are characteristic of discrete populations of elderly AML patients. British Journal of Haematology , 129 39-.

Parker, LL; Anderson, FM; O'Hare, CC; Lacy, SM; Bingham, JP; Robins, DJ; Hartley, JA; (2005) Synthesis of novel DNA cross-linking antitumour agents based on polyazamacrocycles. BIOORGAN MED CHEM , 13 (7) 2389 - 2395. 10.1016/j.bmc.2005.01.055.

Pascolo, S; Ginhoux, F; Laham, N; Walter, S; Schoor, O; Probst, J; Rohrlich, P; ... Rammensee, H-G; + view all (2005) The non-classical HLA class I molecule HFE does not influence the NK-like activity contained in fresh human PBMCs and does not interact with NK cells. Int Immunol , 17 (2) pp. 117-122. 10.1093/intimm/dxh191.

Patel, B; Goldstone, AH; Ross, P; Richards, S; Foroni, L; Chopra, R; Fielding, A; (2005) The impact of imatinib therapy on adult Philadelphia positive acute lymphoblastic leukaemia (ALL): Early results from the UKALL12/ECOG 2993 study. In: (Proceedings) 47th Annual Meeting of the American-Society-of-Hematology. (pp. 523A-523A). AMER SOC HEMATOLOGY

Pedley, RB; El Emir, E; Sharma, SK; Qureshi, U; Dearling, JAB; R, HJ; (2005) Therapeutic effects of the antivascular agent combretastatin A-1 phosphate on orthotopic and subcutaneous colorectal tumours in nude mice. In: (Proceedings) Proceedings American Association for Cancer Research. (pp. 943-).

Peggs, K.S.; Hunter, A.; Chopra, R.; Parker, A.; Mahendra, P.; Milligan, D.; Craddock, C.; ... Mackinnon, S.; + view all (2005) Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation. The Lancet , 365 (9475) pp. 1934-1941. 10.1016/S0140-6736(05)66659-7.

Peggs, KS; (2005) The role of alemtuzumab in allogeneic stem cell transplantation. In: Hillmen, P and Witzig, TE, (eds.) Therapeutic Strategies in Lymphoid Malignancy. (pp. 177-188). Informa HealthCare

Peggs, KS; Allison, JP; (2005) Co-stimulatory pathways in lymphocyte regulation: the immunoglobulin superfamily. BRIT J HAEMATOL , 130 (6) 809 - 824.

Peleg, M; Steele, R; Thomson, R; Patkar, V; Rose, T; Fox, J; (2005) Open-source publishing of medical knowledge for creation of computer-interpretable guidelines. In: Miksch, S and Hunter, J and Keravnou, E, (eds.) ARTIFICIAL INTELLIGENCE IN MEDICINE, PROCEEDINGS. (pp. 156 - 160). SPRINGER-VERLAG BERLIN

Peltenburg, LTC; de Bruin, EC; Meersma, D; Smit, NPM; Schrier, PI; Medema, JP; (2005) Expression and function of the apoptosis effector Apaf-1 in melanoma. Cell Death Differ , 12 (6) pp. 678-679. 10.1038/sj.cdd.4401630.

Perkins, SJ; Gilbert, HE; Lee, YC; Sun, ZF; P, B; (2005) Relating small angle scattering and analytical ultracentrifugation in multidomain proteins. In: Scott, DJ and Harding, SE and Rowe, AJ, (eds.) Modern Analytical Ultracentrifugation: Techniques and Method. (pp. 291-319). Royal Society of Chemistry: London,UK.

Pillay, OC; Wong Te Fong, LF; Crow, JC; Benjamin, E; Mould, T; Atiomo, W; Menon, PA; ... Hardiman, P; + view all (2005) The association between polycystic ovaries and endometrial cancer. Human Reproduction

Plummer, R; Middleton, M; Wilson, R; Jones, C; Evans, J; Robson, L; Steinfeldt, H; ... Calvert, AH; + view all (2005) First in human phase I trial of the PARP inhibitor AG-014699 with temozolomide (TMZ) in patients (pts) with advanced solid tumors. JOURNAL OF CLINICAL ONCOLOGY , 23 (16) 208S - 208S.

Pluzanska, A; Mainwaring, P; Cassidy, J; Utracka-Hutka, B; Zalucki, J; Glynne-Jones, R; Koralewski, P; ... Cunningham, D; + view all (2005) Final results of a randomized phase III study evaluating the addition of oxaliplatin first line to 5-FU followed by irinotecan at progression in advanced colorectal cancer (LIFE study). In: (Proceedings) 41st Annual Meeting of the American-Society-of-Clinical-Oncology. (pp. 250S-250S). AMER SOC CLINICAL ONCOLOGY

Pool-Zobel, BL; Selvaraju, V; Sauer, J; Kautenburger, T; Kiefer, J; Richter, KK; Soom, M; (2005) Butyrate may enhance toxicological defence in primary, adenoma and tumor human colon cells by favourably modulating expression of glutathione S-transferases genes, an approach in nutrigenomics. Carcinogenesis , 26 (6) pp. 1064-1076. 10.1093/carcin/bgi059.

Popat, R; Oakervee, H; Foot, N; Curry, N; Morris, C; Drake, M; Agrawal, S; ... Cavenagh, JD; + view all (2005) PAD (PS-341/bortezomib, adriamycin and dexamethasone) as front-line therapy for untreated patients with multiple myeloma. In: (Proceedings) 45th Annual Scientific Meeting of the British-Society-for-Haematology. (pp. p. 22). BLACKWELL PUBLISHING

Popat, R; Oakervee, HE; Agrawal, S; Smith, P; Singer, C; Craddock, C; Williams, C; ... Cavenagh, JD; + view all (2005) A phase I/II trial of bortezomib and low dose intravenous melphalan (BM) for relapsed multiple myeloma. In: (Proceedings) 45th Annual Scientific Meeting of the British-Society-for-Haematology. (pp. p. 27). BLACKWELL PUBLISHING

Porakishvili, N; Kulikova, N; Jewell, AP; Youinou, PY; Nedelec, S; Yong, K; Nathwani, A; ... Lydyard, PM; + view all (2005) CD180 is more highly expressed by B cell chronic lymphocytic leukaemia (B-CLL) cells using IgVh mutated than those using IgVh unmutated genes. British Journal of Haematology , 131 (3) pp. 313-319.

Pors, K; Phillips, RM; Hartley, JA; Patterson, LH; (2005) N-oxides of alkylating anthraquinones as hypoxia-targeting prodrugs. In: CLINICAL CANCER RESEARCH. (pp. 9053S - 9053S). AMER ASSOC CANCER RESEARCH

Presneau, N; Dewar, K; Forgetta, V; Provencher, D; Mes-Masson, AM; Tonin, PN; (2005) Loss of heterozygosity and transcriptome analyses of a 1.2 Mb candidate ovarian cancer tumor suppressor locus region at 17q25.1-q25.2. MOL CARCINOGEN , 43 (3) 141 - 154. 10.1002/mc.20096.

Presneau, N; Shen, Z; Provencher, D; Mes-Masson, AM; Tonin, PN; (2005) Identification of novel variant, 1484delG in the 3 ' UTR of H3F3B, a member of the histone 3B replacement family, in ovarian tumors. INT J ONCOL , 26 (6) 1621 - 1627.

Preston, S; McDonald, S; Oukrif, D; Greaves, L; Turnbull, D; Tadrous, P; Sasieni, P; ... Wright, N; + view all (2005) Clusters of phenotypically related human colonic crypts develop through crypt fission: Implications for colorectal carcinogenesis. In: GASTROENTEROLOGY. (pp. A493 - A493). W B SAUNDERS CO

Preston, SL; McDonald, SAC; Oukrif, D; Greaves, L; Turnbull, D; Tadrous, P; Sasieni, P; ... Wright, NA; + view all (2005) Clusters of phenotypically related human colonic crypts develop through crypt fission: Implications for colorectal carcinogenesis. In: GUT. (pp. A24 - A24). B M J PUBLISHING GROUP

Price, CA; Lingerfelt, BM; Handl, HL; Kiakos, K; Hartley, JA; Lee, M; (2005) Sequence specific recognition of DNA by tailor-made hairpin conjugates of achiral seco-cyclopropaneindoline-2-benzofurancarboxamide and pyrrole-imidazole polyamides. Bioorg Med Chem Lett , 15 (12) pp. 3151-3156. 10.1016/j.bmcl.2005.04.006.

Pritchard-Jones, K; Spendlove, I; Wilton, C; Whelan, J; Weeden, S; Lewis, I; Hale, J; ... Durrant, LG; + view all (2005) Immune responses to the 105AD7 human anti-idiotypic vaccine after intensive chemotherapy, for osteosarcoma. British Journal of Cancer , 92 (8) pp. 1358-1365. 10.1038/sj.bjc.6602500.

Q

Quaglia, A; Etessami, N; Sim, R; Difford, J; Dhillon, AP; (2005) Vascular invasion and herniation by hepatocellular carcinoma in cirrhosis - A wolf in sheep's clothing? ARCH PATHOL LAB MED , 129 (5) 639 - 644.

Quaglia, A; Jutand, MA; Dhillon, A; Godfrey, A; Togni, R; Bioulac-Sage, P; Balabaud, C; ... Dhillon, AP; + view all (2005) Classification tool for the systematic histological assessment of hepatocellular carcinoma, macroregenerative nodules, and dysplastic nodules in cirrhotic liver. WORLD JOURNAL OF GASTROENTEROLOGY , 11 (40) pp. 6262-6268. 10.3748/wjg.v11.i40.6262. Gold open access

R

Rades, D; Stalpers, LJA; Veninga, T; Hoskin, PJ; (2005) Spinal reirradiation after short-course RT for metastatic spinal cord compression. International Journal of Radiation Oncology Biology Physics , 63 (3) pp. 872-875.

Rades, D; Stalpers, LJA; Veninga, T; Schulte, R; Hoskin, PJ; Alberti, W; (2005) Effectiveness and toxicity of reirradiation (Re-RT) for metastatic spinal cord compression (MSCC). STRAHLENTHERAPIE UND ONKOLOGIE , 181 (9) pp. 595-600.

Rades, D; Stalpers, LJA; Veninga, T; Schulte, R; Hoskin, PJ; Obralic, N; Bajrovic, A; ... Schild, SE; + view all (2005) Evaluation of five radiation schedules and prognostic factors for metastatic spinal cord compression. Journal of Clinical Oncology , 23 (15) pp. 3366-3376.

Raja, FA; Bridgewater, JA; (2005) Survival following first line fluorouracil single agent therapy for advanced colarectal cancer in a cancer unit practice in the United Kingdom (UK). In: JOURNAL OF CLINICAL ONCOLOGY. (pp. 274S - 274S). AMER SOC CLINICAL ONCOLOGY

Ravn, P; Thornton, A; Chester, KA; Pedley, B; Davidson, B; Winslet, M; Ogunbiyi, O; ... Meyer, T; + view all (2005) In situ selection of single chain antibodies by ex vivo perfusion of tumour-bearing human organs with phage display antibody libraries. In: (Proceedings) NCRI Cancer Conference Proceedings.

Reid, AG; Nacheva, EP; (2005) Genesis of derivative chromosome 9 deletions in chronic myeloid leukemia. GENE CHROMOSOME CANC , 43 (2) 223 - 224. 10.1002/gcc.20163.

Renzulli, M; Grafone, T; Taccioli, C; Terragna, C; Boschelli, F; Mancini, M; Creo, P; ... Martinelli, G; + view all (2005) Gene expression profile in the CML cell line K562 treated with SKI-606, a dual inhibitor of Src/Abl kinase. In: BLOOD. (pp. 297B - 298B). AMER SOC HEMATOLOGY

Roberts, CH; Madrigal, JA; Marsh, SGE; (2005) Cloning and sequencing entire KIR genes from genomic DNA. In: (Proceedings) 35th Annual SCientific Meeting of the Australasian-Society-for-Immunology/14th International HLA and Immunogenetics Workshops. (pp. p. 525). BLACKWELL PUBLISHING

Robertson, JFR; Come, SE; Jones, SE; Beex, L; Kaufmann, M; Makris, A; Nortier, JWR; ... Rutqvist, LE; + view all (2005) Endocrine treatment options for advanced breast cancer - the role of fulvestrant. EUROPEAN JOURNAL OF CANCER , 41 (3) pp. 346-356.

Rodriguez, T; Mendez, R; Roberts, CH; Ruiz-Cabello, F; Dodi, IA; Nevot, MAL; Paco, L; ... Garrido, F; + view all (2005) High frequency of homozygosity of the HLA region in melanoma cell lines reveals a pattern compatible with extensive loss of heterozygosity. CANCER IMMUNOLOGY IMMUNOTHERAPY , 54 (2) pp. 141-148. 10.1007/s00262-004-0561-5.

Rodriguez-Viciana, P; Tetsu, O; Oda, K; Okada, J; Rauen, K; McCormick, F; (2005) Cancer targets in the Ras pathway. Molecular Approaches to Controlling Cancer , 70 461 - 467.

Rogers, SL; Gobel, TW; Viertlboeck, BC; Milne, S; Beck, S; Kaufman, J; (2005) Characterization of the chicken C-type lectin-like receptors B-NK and B-lec suggests that the NK complex and the MHC share a common ancestral region. J IMMUNOL , 174 (6) 3475 - 3483.

Roos, DE; Turner, SL; O'Brien, PC; Smith, JG; Spry, NA; Burmeister, BH; Hoskin, PJ; (2005) Randomized trial of 8 Gy in 1 versus 20 Gy in 5 fractions of radiotherapy for neuropathic pain due to bone metastases (Trans-Tasman Radiation Oncology Group, TROG 96.05). Radiotherapy & Oncology , 75 (1) pp. 54-63.

Rowe, JM; Buck, G; Burnett, AK; Chopra, R; Wiernik, PH; Richards, SM; Lazarus, HM; ... Goldstone, AH; + view all (2005) ECOG; MRC/NCRI Adult Leukemia Working Party. Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993. Blood , 106 (12) pp. 3760-3767. 10.1182/blood-2005-04-1623.

Rubio, MT; Means, TK; Chakraverty, R; Shaffer, J; Fudaba, Y; Chittenden, M; Luster, AD; (2005) Maturation of human monocyte-derived dendritic cells (MoDCs) in the presence of prostaglandin E-2 optimizes CD4 and CD8 T cell-mediated responses to protein antigens: role of PGE(2) in chemokine and cytokine expression by MoDCs. INTERNATIONAL IMMUNOLOGY , 17 (12) pp. 1561-1572. 10.1093/intimm/dxh335.

Rudd, R.M.; Gower, N.H.; Spiro, S.G.; Eisen, T.G.; Harper, P.G.; Littler, J.A.H.; Hatton, M.; ... Lee, S.M.; + view all (2005) Gemcitabine plus Carboplatin versus Mitomycin, Ifosfamide, and Cisplatin in patients with stage IIIB or IV non–small-cell lung cancer: a phase III randomized study of the London Lung Cancer Group. Journal of Clinical Oncology , 23 (1) pp. 142-153. Green open access
file

Rudd, R.M.; Gower, N.H.; Spiro, S.G.; Eisen, T.G.; Harper, P.G.; Littler, J.A.H.; Hatton, M.; ... Lee, S.M.; + view all (2005) Gemcitabine plus carboplatin versus mitomycin, ifosfamide, and cisplatin in patients with stage IIIB or IV non-small-cell lung cancer: a phase III randomized study of the London Lung Cancer Group. Journal of Clinical Oncology , 23 (1) pp. 142-153. 10.1200/JCO.2005.03.037.

S

Saich, R; Collins, P; Ala, A; Standish, R; Hodgson, H; (2005) Benign recurrent intrahepatic cholestasis with secondary renal impairment treated with extracorporeal albumin dialysis. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY , 17 (5) pp. 585-588. 10.1097/00042737-200505000-00018.

Sainz-Pastor, N; Tolner, B; Huhalov, A; Kogelberg, H; Begent, RHJ; Chester, KA; (2005) Expression and purification of recombinant carcinoembryonic antigen frm the yeast Pichia pastoris. In: (Proceedings) NCRI Cancer Conference Proceedings.

Sainz-Pastor, N; Tolner, B; Huhalov, A; Kogelberg, H; Begent, RHJ; Chester, KA; (2005) Expression and purification of recombinant carcinoembryonic antigen from the yeast Pichia pastoris. In: (Proceedings) NCRI Cancer Conference Proceedings.

Sainz-Pastor, N; Tolner, B; Huhalov, A; Kogelberg, H; Lee, YC; Zhu, DL; Begent, RHJ; (2005) Deglycosylation to obtain stable and homogeneous Pichia pastoris-expressed N-A1 domains of carcinoembryonic antigen. International Journal of Biological Macromolecules , 39 (1 -3) pp. 141-150.

Samonakis, DN; Cholongitas, E; Triantos, CK; Quaglia, A; Senzolo, M; Dhillon, AP; Sharma, D; ... Burroughs, AK; + view all (2005) Randomised trial of tacrolimus monotherapy vs. tacrolimus/azathioprine/prednisolone after liver transplantation for HCV cirrhosis: Preliminary results. JOURNAL OF HEPATOLOGY , 42 47 - 47.

Sato, A; McNulty, L; Cox, K; Kim, S; Scott, A; Daniell, K; Summerville, K; ... Lee, M; + view all (2005) A novel class of in vivo active anticancer agents: achiral seco-amino- and seco-hydroxycyclopropylbenz[e]indolone (seco-CBI) analogues of the duocarmycins and CC-1065. J Med Chem , 48 (11) pp. 3903-3918. 10.1021/jm050179u.

Scaffidi, P; Gordon, L; Misteli, T; (2005) The Cell Nucleus and Aging: Tantalizing Clues and Hopeful Promises. PLoS Biology , 3 (11) e395-e395. 10.1371/journal.pbio.0030395.

Scaffidi, P; Misteli, T; (2005) Reversal of the cellular phenotype in the premature aging disease Hutchinson-Gilford progeria syndrome. Nature Medicine , 11 (43) pp. 440-445. 10.1038/nm1204.

Schaefer, E; Mehta, A; Gal, A; (2005) Genotype and phenotype in Fabry disease: analysis of the Fabry Outcome Survey. Acta Paediatrica , 94 (Suppl 44) pp. 87-92. 10.1080/08035320510031045.

Schaefer, E; Mehta, A; Gal, A; (2005) Vascular complications of Fabry disease: enzyme replacement and other therapies. Acta Paediatrica - Supplement , 94 (447) pp. 87-92.

Schafer, E; Baron, K; Widmer, U; Deegan, P; Neumann, HP; Sunder-Plassmann, G; Johansson, JO; ... Gal, A; + view all (2005) Thirty-four novel mutations of the GLA gene in 121 patients with Fabry disease. Human Mutation , 25 (4) 412-.

Schreuder, GMT; Hurley, CK; Marsh, SGE; Lau, M; Fernandez-Vina, M; Noreen, HJ; Setterholm, M; (2005) The HLA Dictionary 2004: a summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens. Human Immunology , 66 pp. 170-210.

Schreuder, GMT; Hurley, CK; Marsh, SGE; Lau, M; Fernandez-Vina, M; Noreen, HJ; Setterholm, M; (2005) The HLA Dictionary 2004: a summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens. Tissue Antigens , 65 pp. 1-55.

Schreuder, GMT; Hurley, CK; Marsh, SGE; Lau, M; Fernandez-Vina, M; Noreen, HJ; Setterholm, M; (2005) The HLA Dictionary 2004: a summary of HLA-A, -B, -C,-DRB1/3/4/5 and-DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens. TISSUE ANTIGENS , 65 (1) pp. 1-55. 10.1111/j.1399-0039.2004.00350.x.

Schwarting, A; Dehout, F; Feriozzi, S; Beck, M; Mehta, A; Widmer, U; Sunder-Plassmann, G; (2005) Agalsidase alfa prevents the decline in renal function in patients with Fabry disease. Nephrology Dialysis Transplantation , 20 V248-.

Scully, M; Cavenagh, J; Hagger, D; Benjamin, S; Mackie, I; Mchin, SJ; Cohen, H; (2005) Normalisation of ADAMTS 13 activity and disappearance of ADAMTS 13 antibody following rituximab in acute refractory thrombotic thrombocytopenic purpura. In: BLOOD. (pp. 357A - 358A). AMER SOC HEMATOLOGY

Scully, M; Starke, R; Flynn, M; Haggar, D; Mackie, IJ; Machin, S; Cohen, H; (2005) Use of rituximab in acute refractory thrombotic thrombocytopenic purpura. In: (Proceedings) British society for haematology annual scientific meeting.

Seddon, BM; Cassoni, AM; Galloway, MJ; Rees, JH; Whelan, JS; (2005) Fatal radiation myelopathy after high-dose busulfan and melphalan chemotherapy and radiotherapy for Ewing's sarcoma: A review of the literature and implications for practice. CLIN ONCOL-UK , 17 (5) 385 - 390. 10.1016/j.clon.2005.03.004.

Seddon, BM; McTiernan, AM; Michelagnoli, MP; Gabbie, S; Daw, S; Whelan, JS; (2005) High-dose ifosfamide in relapsed or progressive Ewing's sarcoma. In:

Seldon, PM; Meja, KK; Giembycz, MA; (2005) Rolipram, salbutamol and prostaglandin E2 suppress TNFalpha release from human monocytes by activating Type II cAMP-dependent protein kinase. Pulm Pharmacol Ther , 18 (4) pp. 277-284. 10.1016/j.pupt.2004.12.012.

Selvasekar, CR; Mackenzie, GD; Clark, BR; Novelli, MR; Thorpe, SM; Mosse, CA; Bown, SG; (2005) Randomised controlled trial of photodynamic therapy using low dose 5 aminolevulinic acid activated by red or green light for high grade dysplasia in Barrett's oesophagus. In: GUT. (pp. A54 - A55). B M J PUBLISHING GROUP

Shah, JS; Hughes, D; Tayebjee, MH; MacFadyen, R; Mehta, A; Elliott, PM; (2005) Extracellular matrix turnover in patients with Anderson-Fabry disease. In: EUROPEAN HEART JOURNAL. (pp. 398 - 398). OXFORD UNIV PRESS

Shah, JS; Hughes, DA; Sachdev, B; Tome, M; Ward, D; Lee, P; Mehta, AB; (2005) Prevalence and clinical significance of cardiac arrhythmia in Anderson-Fabry disease. The American Journal of Cardiology , 96 (6) pp. 842-846.

Shah, JS; Lee, P; Hughes, D; Thaman, R; Sachdev, B; Pellerin, D; Mehta, A; (2005) The natural history of left ventricular systolic function in Anderson-Fabry disease. HEART , 91 (4) 533 - 534. 10.1136/hrt.2004.035584.

Sharma, S.K.; Pedley, R.B.; Bhatia, J.; Boxer, G.M.; El-Emir, E.; Qureshi, U.; Tolner, B.; ... Chester, K.; + view all (2005) Sustained tumor regression of human colorectal cancer xenografts using a multifunctional mannosylated fusion protein in antibody-directed enzyme prodrug therapy. Clinical Cancer Research , 11 (2) pp. 814-825.

Sharma, SK; Bagshawe, KD; Begent, RHJ; (2005) Advances in antibody-directed enzyme prodrug therapy. Curr Opin Investig Drugs , 6 (6) pp. 611-615.

Sharma, SK; Griffin, N; Mayer, A; Tolner, B; Shahbakhti, H; Chester, KA; Begent, RHJ; (2005) Immunogenicity of a glycosylates antibody-enzyme fusion protien (MFECP1) in a phase I/II clinical study of ADEPT. In: (Proceedings) NCRI Cancer Conference Proceedings.

Sharma, SK; Pedley, RB; Meyer, A; Tolner, B; Griffin, N; Green, A; Boxer, GM; ... and Chester, KA; + view all (2005) Pharmacokinetics and pharmakodynamics of a glycosylated antibody-enzyme fusion protein for ADEPT. In: (Proceedings) Proceedings American Association for Cancer Research. (pp. 984-).

Shaw, BE; Byrne, JL; Das-Gupta, E; Carter, I; Russell, NH; (2005) Converting mixed chimerism to full donor chimerism in recipients of campath-containing reduced intensity transplants reduces the relapse risk and results in significantly improved survival compared to those with persistent full donor chimerism. In: BLOOD. (pp. 573A - 573A). AMER SOC HEMATOLOGY

Shaw, BE; Gilyead, M; Das-Gupta, E; Madrigal, JA; Byrne, JL; Russell, NH; (2005) Donor factors are significantly associated with primary non-engraftment in recipients of reduced intensity conditioned (RIC) transplants from unrelated donors. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 41 - 41). BLACKWELL PUBLISHING

Shaw, BE; Marsh, SGE; Mayor, NP; Madrigal, A; (2005) Particular HLA-DPB1 allele mismatches predict for worse overall survival in recipients of unrelated donor haematopoietic stem cell transplants. In: BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. (pp. 13 - 13). CARDEN JENNINGS PUBL CO LTD

Shaw, BE; Russell, NH; Devereux, S; Emma, DG; Stephen, M; Madrigal, JA; Pagliuca, A; ... Byrne, JL; + view all (2005) Single HLA allele mismatches are well tolerated in the recipients of T cell depleted reduced intensity conditioned transplants from unrelated donors. In: BLOOD. (pp. 812A - 812A). AMER SOC HEMATOLOGY

Short, S; Bourne, S; Martindale, C; Woodcock, M; Jackson, SP; (2005) DNA damage responses at low radiation doses. Radiation Research , 164 (3) pp. 292-302. 10.1667/RR3421.1.

Short, S; Buffa, F; Koritzinsky, M; Wouters, B; Bentzen, SM; (2005) Radiation induced changes in gene expression in human glioma cells. In:

Short, S; C, B; F, K; M, W; B, B; S, M; (2005) UNSPECIFIED In: (Proceedings) 6th Wolfsberg Conference on Molecular Radiation Biology/Oncology.

Short, S; Hoskin, P; Wong, W; (2005) Ovulation and increased FDG uptake on PET: Potential for a false-positive result. LIPPINCOTT WILLIAMS & WILKINS, 530 WALNUT ST, PHILADELPHIA, PA 19106-3261 USA

Sieben, NLG; Oosting, J; Flanagan, AM; Prat, J; Roemen, GMJM; Kolkman-Uljee, SM; van Eijk, R; ... van Engeland, M; + view all (2005) Differential gene expression in ovarian tumors reveals Dusp 4 and Serpina 5 as key regulators for benign behavior of serous borderline tumors. J CLIN ONCOL , 23 (29) 7257 - 7264. 10.1200/JCO.2005.02.2541.

Simpson, CL; Knight, J; Butcher, LM; Hansen, VK; Meaburn, E; Schalkwyk, LC; Craig, IW; ... Al-Chalabi, A; + view all (2005) A central resource for accurate allele frequency estimation from pooled DNA genotyped on DNA microarrays. Nucleic Acids Res. , 33 (3) , Article e25. 10.1093/nar/gni028.

Stainsby, D; Cohen, H; Jones, H; (2005) The 2004 annual SHOT report (on behalf of the serious hazards of transfusion steering group).

Stainsby, D; Jones, H; Chapman, J; Hick, R; Cohen, H; (2005) Understanding SHOT data: encouraging active participation and putting the findings into context. Presented at: British society for haematology annual scientific meeting, Manchester.

Stainsby, D; Russell, J; Cohen, H; Lilleyman, J; (2005) Reducing adverse events in blood transfusion. British journal of haematology , 131 pp. 8-12.

Starke, R; Harrison, P; Mackie, I; Wang, G; Erusalimsky, JD; Gale, R; Masse, JM; ... Machin, S; + view all (2005) The expression of prion protein (PrPc) in the megakaryocyte lineage. J THROMB HAEMOST , 3 (6) 1266 - 1273.

Starke, R; Harrison, P; Mackie, I; Wang, G; Erusalimsky, JD; Gale, R; Massé, JM; ... Machin, S; + view all (2005) The expression of prion protein (PrP<sup>C</sup>) in the megakaryocyte lineage. Journal of Thrombosis and Haemostasis , 3 (6) pp. 1266-1273. 10.1111/j.1538-7836.2005.01343.x.

Stebbing, J; Mandalia, S; Young, AM; Dhillon, T; Newshom-Davis, T; Thirlwell, C; Powles, T; ... Bower, M; + view all (2005) A new prognostic index for systemic AIDS-related lymphoma. In: JOURNAL OF CLINICAL ONCOLOGY. (pp. 844S - 844S). AMER SOC CLINICAL ONCOLOGY

Steward, CG; Blair, A; Moppett, J; Clarke, E; Virgo, P; Lankester, A; Burger, SR; ... Orchard, PJ; + view all (2005) High peripheral blood progenitor cell counts enable autologous backup before stem cell transplantation for malignant infantile osteopetrosis. BIOL BLOOD MARROW TR , 11 (2) 115 - 121. 10.1016/j.bbmt.2004.11.001.

Stigliano, R; Marelli, L; Pang, K; Lowdell, M; Rolles, K; Patch, D; Burroughs, AK; (2005) G-CSF mobilization of bone marrow-derived hepatocye and haematopoietic progenitors in acute alcoholic hepatitis - A randomised controlled trial. Preliminary data. HEPATOLOGY , 42 (4) 741A-741A.

Stigliano, R; Marelli, L; Senzolo, M; Pang, C; Lowdell, M; Patch, D; Rolles, K; ... Burroughs, AK; + view all (2005) Peripheral hepatic and haematopoietic stem cells after partial hepatectomy: Preliminary data. GUT , 54 A48-A48.

Stigliano, R; Marelli, L; Senzolo, M; Pang, K; Lowdell, M; Davies, N; Tibballs, J; ... Burroughs, AK; + view all (2005) Are CD34+ cells increased in perpheral blood of patients with HCC. Preliminary data. HEPATOLOGY , 42 (4) 742A-743A.

Stigliano, R; Morelli, L; Senzolo, M; Morisco, F; Pang, C; Lowdell, M; Patch, D; ... Burroughs, AK; + view all (2005) Circulating progenitor cells after vascular injury. GUT , 54 A48-A49.

Stoeber, K; (2005) Book Review: Principles of Molecular Pathology. British Journal of Cancer , 92 p. 1177.

Stoeber, K; Eward, KL; Kingsbury, SR; Okorokov, AL; Madge, D; Selwood, DL; Williams, GH; (2005) Development of geminin mimetics as novel anti-proliferative agents. In: JOURNAL OF PATHOLOGY. (pp. 6 - 6). JOHN WILEY & SONS LTD

Strachan, D; Hackshaw, AK; (2005) Health effects of environmental tobacco smoke. In: Britton, J and Edwards, R, (eds.) Going smoke-free: the medical case for clean air in the home, at work and in public places. A report on passive smoking of the Tobacco Advisory Group of the Royal College of Physicians. (pp. 13-28). Royal College of Physicians

Streck, CJ; Zhang, YB; Zhou, JF; Ng, C; Nathwani, AC; Davidoff, AM; (2005) Adeno-associated virus vector-mediated delivery of pigment epithelium-derived factor restricts neuroblastoma angiogenesis and growth. JOURNAL OF PEDIATRIC SURGERY , 40 (1) 236 - 243. 10.1016/j.jpedsurg.2004.09.049.

T

Taher, A; Sheikh-Taha, M; Sharara, A; Inati, A; Koussa, S; Ellis, G; Dhillon, AP; (2005) Safety and effectiveness of 100 mg/kg/day deferiprone in patients with thalassemia major: A two-year study. ACTA HAEMATOL-BASEL , 114 (3) 146 - 149. 10.1159/000087888.

Taherbhai, Z; Bailey, S; Sutterfield, A; Buchmueller, K; Nguyen, B; Kotecha, M; Hochhauser, D; ... Lee, M; + view all (2005) ZT-65B, a hairpin polyamide that binds to the inverted CCAAT box (ICB) site of the human multidrug resistant (MDR1) gene: Design, DNA binding, and biological studies. In: ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY. (pp. U542 - U543). AMER CHEMICAL SOC

Taylor, NJ; Ah-See, ML; Stirling, JJ; d'Arcy, JA; Collins, DJ; Walker-Samuel, S; Leach, MO; ... Padhani, AR; + view all (2005) Pre-and post-chemotherapy comparisons of calculated rBV and rBF with signal intensity drop on T2* dynamic contrast-enhanced MRI of breast cancers. In: (pp. p. 91).

Thom, M; Martinian, L; Williams, G; Stoeber, K; Cross, H; Harding, BN; Sisodiya, SM; (2005) Geminin expression in balloon cells in focal cortical dysplasia (FCD) type IIB. EPILEPSIA , 46 368 - 368.

Thom, M; Martinian, L; Williams, G; Stoeber, K; Cross, H; Harding, BN; Sisodiya, SM; (2005) Geminin expression in balloon cells in focal cortical dysplasia (FCD) type IIB. In: (Proceedings) 26th International Epilepsy Congress. (pp. p. 368). Wiley: Hoboken, US.

Thomas, MJ; Smith, A; Head, DH; Milne, L; Nicholls, A; Pearce, W; Vanhaesebroeck, B; ... Westwick, J; + view all (2005) Airway inflammation: chemokine-induced neutrophilia and the class I phosphoinositide 3-kinases. EUROPEAN JOURNAL OF IMMUNOLOGY , 35 (4) pp. 1283-1291. 10.1002/eji.200425634.

Thomson, A; Mayne, N; Bamford, A; Daw, S; Whelan, J; Michelagnoli, M; (2005) Acute anthracycline-induced cardiotoxicity in children and adolescents treated for bone cancer. In:

Thomson, KJ; Peggs, KS; (2005) Role of allogeneic stem cell transplantation in multiple myeloma. EXPERT REV ANTICANC , 5 (3) 455 - 464. 10.1586/14737140.5.3.455.

Tolner, B; Taylorson, CJ; Kogelberg, H; Huhalov, S; Robson, L; Begent, RHJ; Chester, KA; (2005) A humanized ADEPT system using mutated human pancreatic ribonuclease. In: (Proceedings) NCRI Cancer Conference Proceedings.

Torres, HM; Robinson, J; Madrigal, JA; Marsh, SGE; (2005) Cactus, a population genetics analysis environment. In: (Proceedings) 35th Annual SCientific Meeting of the Australasian-Society-for-Immunology/14th International HLA and Immunogenetics Workshops. (pp. p. 486). BLACKWELL PUBLISHING

Torres-Rendon, A; Craig, GT; Loddo, M; Stoeber, K; Williams, GH; Speight, PM; (2005) Expression of novel cell cycle markers in normal oral mucosa and oral epithelial dysplasias. In: ORAL ONCOLOGY. (pp. 86 - 86). ELSEVIER SCIENCE BV

Toth, JL; Trzupek, JD; Flores, LV; Kiakos, K; Hartley, JA; Pennington, WT; Lee, M; (2005) A novel achiral seco-amino-cyclopropylindoline (CI) analog of CC-1065 and the duocarmycins: design, synthesis and biological studies. Med Chem , 1 (1) pp. 13-19.

Tsuzuki, S; Hong, DL; Eguchi, M; Eguchi, M; Greaves, M; Brown, J; Gupta, R; (2005) Developmental impact of leukaemia associated fusion genes on stem cell fate. In: (Proceedings) 14th Conference on Hemoglobin Switching. (pp. p. 85). ACADEMIC PRESS INC ELSEVIER SCIENCE

Turnell, AS; Stewart, GS; Grand, RJ; Rookes, SM; Martin, A; Yamano, H; Elledge, SJ; (2005) The APC/C and CBP/p300 cooperate to regulate transcription and cell-cycle progression. Nature , 438 (7068) pp. 690-695.

U

UCL Business, PLC; Selwood, DL; Visintin, C; Laman, H; Okuyama, M; (2005) Bi- or tetra-guanidino-biphenyl compounds as small molecule carriers. WO/2005/123676.

V

UNSPECIFIED (Ed). (2005) Novel implantable delivery system increases maximum tolerable doses of paclitaxel in mice. [Whole issue]. Proc Amer Assoc Cancer Res , 46

Venables, K; Miles, EA; Hoskin, PJ; Aird, EGA; (2005) Verification films: A study of the daily and weekly reproducibility of breast patient set-up in the START trial. Clinical Oncology , 17 (5) pp. 337-342.

Vigor, K; Lee, YC; Farrell, D; Huhalov, S; Robson, L; Begent, RHJ; Chester, KA; (2005) Antibody-nanoparticle complexation for hyperthermic treatment of tumours. In: (Proceedings) NCRI Cancer Conference Proceedings.

Violet, JA; Dearling, JLJ; Marley, SJ; Green, AJ; Begent, RHJ; and, PRB; (2005) Dose fractionation reduces efficacy of radioimmunotherapy without decreasing toxicity. In: (pp. 207-).

Vujovic, S; Henderson, SR; Clements, MO; Flanagan, AM; (2005) Patterns of gene expression and novel factors involved in cartilage development identified through transcriptional analysis of hMSC chondrogenesis.

W

Wald, NJ; Rodeck, C; Hackshaw, AK; Rudnicka, A; (2005) The future of antenatal screening for Down's Syndrome - Reply. BJOG-INT J OBSTET GY , 112 (1) ? - ?. 10.1111/j.1471-0528.2005.00475.x.

Walton, J; Lawson, K; Manoussaka, MS; Nathwani, A; Emory, V; Lydyard, PM; Porakishvili, N; (2005) CD4(+) perforin(+) T cells in B-CLL: MHC class II restriction and anti-cytomegalovirus reactivity. In: BLOOD. (pp. 325B - 326B). AMER SOC HEMATOLOGY

Wang, HW; Boshoff, C; (2005) Linking Kaposi virus to cancer-associated cytokines. TRENDS MOL MED , 11 (7) 309 - 312.

Westbury, C; Yarnold, J; (2005) Can a 'low risk' subgroup be identified in whom radiotherapy can safely be omitted after breast conservation surgery? In: MD, RL, (ed.) The effective management of breast cancer.

Westin, J; Lagging, LM; Dhillon, AP; Hellstrand, K; Norkrans, G; Romero, A; Pawlotsky, JM; ... Neumann, AU; + view all (2005) Steatosis does not affect the result of antiviral treatment in HCV genotype 3 infected patients. In: JOURNAL OF HEPATOLOGY. (pp. 227 - 227). ELSEVIER SCIENCE BV

Westwood, C; Henderson, SR; Boshoff, C; Clements, MO; (2005) Early molecular regulation of adipogenesis in human mesenchymal stem cells.

Whelan, JS; (2005) Osteosarcoma. In: Eden, OB and Barr, R and Bleyer, A and Whiteson, M, (eds.) Cancer and the Adolescent. Blackwell Publishing: Oxford.

Whelan, JS; McTiernan, AM; Weston, C; Ahrens, S; Grimer, R; Lewis, I; Douglas, C; ... Craft, A; + view all (2005) Differences in survival between Study Groups detected in an international randomised study: analysis of Eicess 92. In:

Whitelegg, AM; Oosten, LE; Jordan, S; Kester, M; van, HAG; Madrigal, JA; Goulmy, E; ... L, ; + view all (2005) Investigation of peptide involvement in T cell allorecognition using recombinant HLA class I multimers. The Journal of Immunology , 175 (3) pp. 1706-1714.

Williams, GH; Eward, KL; Kingsbury, SR; Okorokov, AL; Stoeber, K; (2005) Geminin is a critical regulator of growth in human somatic and germ cells. In: JOURNAL OF PATHOLOGY. (pp. 39 - 39). JOHN WILEY & SONS LTD

Williams, KE; Gardiner, C; Mackie, IJ; Machin, SJ; Cohen, H; (2005) Can oral anticoagulation be managed using telemedicine and patient self-testing? A pilot study. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 57 - 57). BLACKWELL PUBLISHING

Williams, KE; Gardiner, C; Mackie, IJ; Machin, SJ; Cohen, H; (2005) Can oral anticoagulation be managed using telemedicine and patient self-testing? A pilot study. In: (Proceedings) British society for haematology annual scientific meeting.

Wilson, GA; Bertrand, N; Patel, Y; Hughes, JB; Feil, EJ; Field, D; (2005) Orphans as taxonomically restricted and ecologically important genes. Microbiology , 151 (Pt 8) pp. 2499-2501.

Wilson, JRF; Pathak, H; Staff, AC; Harsem, NK; Braekke, K; Rees, MCP; Sargent, IL; (2005) Expression of adrenomedullin and its receptor in third trimester placental bed decidua from normal and pre-eclamptic pregnancies. PLACENTA , 26 (8-9) A54 - A54.

Winter, M; Keeling, D; Sharpen, F; Cohen, H; Vallance, P; Haemostasis, ; Thrombosis Task Force of the British Committee for Standards in, H; (2005) Procedures for the outpatient management of patients with deep venous thrombosis. Clinical and laboratory haematology , 27 pp. 61-66.

Y

Yarranton, H; Lawrie, AS; Mackie, IJ; Pinkoski, L; Corash, L; Machin, SJ; (2005) Coagulation factor levels in cryosupernatant prepared from plasma treated with amotosalen hydrochloride (S-59) and ultraviolet A light. TRANSFUSION , 45 (9) 1453 - 1458. 10.1111/j.1537-2995.2005.00551.x.

This list was generated on Sun Apr 15 02:49:18 2018 BST.